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I N T R O D U C T I O N 
Lipophilic drugs, food additives, and environmental pollu­
tants, that enter the body via ingestion, inhalation, or pe­
netration through the skin, have a tendency to accumulate 
in the fatty tissues or to remain bound to certain proteins. 
They can only be cleared from the body after a more or less 
extensive alteration of their chemical structure. The reac­
tions leading to these alterations are catalyzed by the bio­
transformation enzymes, which are predominantly localized in 
the liver. 
Oxidations and conjugations are the main types of biotrans­
formation processes. The oxidative metabolism of drugs, ste­
roids and fatty acids is mediated by an enzyme system in the 
endoplasmic reticulum of the liver, which consists of a 
CO-binding hemoprotein (cytochrome Ρ-450), NADPH-cytochrome 
Ρ-450 reductase and lipid1'2. 
The hemoprotein and the flavoprotein, cytochrome Ρ-450 reduc­
tase, have been partially purified . Study of this enzyme 
system is facilitated by the fact that the spectrum of the 
cytochrome, and changes therein through ligand binding or in­
duction, can be directly measured. Through oxidation many 
compounds groups to which conjugating moieties can be easily 
attached. Oxidations and conjugations are therefore called 
phase-I and phase-II reactions, respectively. 
Conjugation with sugar groups (in particular glucuronic acid), 
glycine, taurine, glutathione and sulfate are the most im­
portant phase II reactions. Conjugations of the first type 
are the subject of this thesis and will be discussed below. 
7 
A wellknown example for conjugation with glycine is the for­
mation of hippuric acid from benzoic acid. 
Glycine and taurine conjugation are important for the meta­
bolism of bile acids. Enzymically these are interesting 
reactions. In a first, ATP-requiring step, the substrate re­
acts with CoA-SH to form a substrate-S-CoA complex. This 
step is catalyzed by a microsomal enzyme. In a second step 
the substrate is transferred from the intermediate complex 
to glycine or taurine and this step is probably catalyzed 
4 
by a lysosomal enzyme . 
Glutathione conjugation plays an important role by the deto­
xification of alkylating agents. 
The glutathione S-transferases catalyzes the conjugation of 
glutathione with a number of compounds bearing an electro-
philic center. They have been subdivided in aryl-, alkyl-, 
aralkyl and epoxide-transferases but this nomenclature has 
recently been challenged. Four different enzymes with over­
lapping substrate specificities have been purified from rat 
6 7 liver cytosol ' . Glutathione conjugation is the initial 
step by the formation of the mercapturic acids . 
Phenols, steroids and tyrosine can form sulfate conjugates. 
Catalyzed by a sulfotransferase the sulfate group of 3'-phos-
phoadenylsulfate is transferred to an accepter substrate. 
There are indications that a whole family of sulfotransfera-
ses exists. Some of them have been partially purified from 
ρ 
liver cytosol . 
Besides conjugating enzymes, the body contains numerous hy­
drolases. This allows the possibility of a fine regulation 
of the metabolic processes. Some of the hydrolases, e.g. 
9 10 
sulfohydrolases and glucuronidases , may catalyze trans-
conjugations. The hydrolytic enzymes are stored in the lyso-
somes but also the endoplasmic reticulum contains sulfohy-
9 11 
drolases and ß-glucuronidases 
8 
Uridine diphosphate glucuronic acid and related sugare 
12 UDPgiucuronic acid is formed by oxidation from UDPglucose 
12 UDPglucose dehydrogenase , a cytoplasmic enzyme, catalyzes 
the two oxidation steps which are required to convert the 
hydroxyl group of a primary alcohol into a carboxyl group. 
The intermediate of this reaction has not been detected but 
13 
UDP-diglucoaldose is the most likely candidate . The over-
all reaction requires two molecules of NAD ' . UDPglucose, 
which is also the main precursor of glycogen synthesis, is 
formed from ct-D-glucose-l-phosphate and UTP by a pyrophos-
phatase 10'13. 
Besides the activity of UDPglucuronyltransferase, the possi-
bility of glucuronide formation in vivo depends on the avai-
lability of the donor nucleotide. The concentration of 
UDPgiucuronic acid in the cell is determined by the availa-
bility of UDPglucose, the activity of UDPglucose dehydroge-
nase, the utilization of UDPgiucuronic acid in conjugation 
reactions, and its breakdown by pyrophosphatases and phos-
phatases. It has, for example, been shown, with liver homo-
genates of rats with experimentally induced diabetes through 
insulin deficiency, that the glucuronide formation was im-
paired whereby a decreased UDPglucose dehydrogenase activity 
14 
was probably the rate limiting factor . 
Decarboxylation of UDPgiucuronic acid leads to the formation 
of UDP-xylose, which is an allosteric regulator of the oxi-
dation of UDPglucose to UDPgiucuronic acid ' . UDPgiucuro-
nic acid, UDPxylose, UDP-N-acetyl glucosamine, UDP-N-acetyl 
galactosamine and UDPgalactose are important by the forma-
tion of mucopolysaccharides whereby they serve as donor sub-
strates for donation of the sugar moieties . In recent re-
ports attention has been paid to the conjugation of small 
molecular compounds with sugars other than glucuronic acid 
and formation of glucuronic acid and formation of gluco-
9 
sides ' ' , xylosides , galactosides galacturoni-
i О д J O 
des and conjugates with N-acetylglucosamine have been 
reported. 
Glucuronide formation 
The formation of (J^D-glucosiduronates, or glucuronides, oc­
curs by transference of the glucuronyl group of uridine 
S'-pyrophosphate-D-glucopyranosiduronic acid to a suitable 
aglycone. Only UDPglucuronic acid with an internal α-link 
20 21 
can serve as donor of the sugar group ' . During formation 
of glucuronides an inversion of this link occurs as ß-glucu-
ronides are formed. It has been postulated that this can oc-
cur by nucleophilic substitution in which the electron dona-
ting aglycon displaces UDP from the opposite side of the e-
22 lectrophilic anomeric C-atom of UDPglucuronic acid 
Glucuronic acid and glucuronic acid 1-phosphate cannot serve 
as donor substrates, nor can glucuronolactone . Only certain 
N-glucuronides can be formed in the presence of glucuronic 
acid, but this occurs non-enzymically . It has been postu-
lated that, in vitro, glucuronyl transfer can occur from the 
glucuronides of e.g. stilbestrol, phenol, menthol and Phe-
nolphthalein to alcohols. The reaction occurs in the presen-
23 
ce of a 3-glucuronidase-like enzyme . These findings however 
still await rigorous confirmation. 
The glucuronidation of p-nitrophenol is a reversible reac-
24 
tion . This opens the possibility of glucuronyl transfer 
from a glucuronide to an aglycone, with UDPglucuronic acid 
as an intermediate 
Recently, it has been reported that p-nitrophenol-glucuroni-
de can serve as the donor of the glucuronyl group by the glu-
curonidation of o-aminophenol in the presence of UDP and gui-
25 
nea pig liver microsomes 
10 
РкаттасоЪодгсаІ oonsequenae of glucuvonidation 
For a heterogeneous group of compounds, glucuronidation is 
either the only form of metabolic conversion or is a phase 
II reaction which enables the drug, after some form of oxi­
dation, to be rapidly cleared from the body. Clearance of 
glucuronides occurs by means of renal excretion and/or se­
cretion into the bile and removal from the body with the 
feces. 
Glucuronides are efficiently cleared by the kidneys. Because 
of their low lipid solubility, glucuronides are not reabsor­
bed to a great extent and more specifically, many glucuroni-
26 
des are actively excreted by the kidney tubules . The bi­
liary excretion of glucuronides occurs, presumably, exclusi-
27 28 
vely by means of active processes ' 
Why some glucuronides are excreted by the kidneys and others 
by means of biliary excretion is not yet explained. There is 
a general tendency for compounds with large molecular weight 
to be excreted in the bile whereas smaller compounds are ex­
creted by the kidneys, but also other and probably more im-
29 portant factors play a role 
The pharmacological activity of glucuronides is low when 
compared with the parent drug. For example the glucuronides 
of chloramphenicol, sulfadimethoxine, and 3'»S'-dibromosul-
29a fanilide have negligible antibacterial activity in vitro , 
and also the glucuronide of morphine does not have a pharma­
cological effect in animals . Glucuronides are relatively 
strong organic acids with pKa values between 3.0 and 4.0 , 
as a result of which they are in the ionized state of phy-
sioligical pH. This means that they can only penetrate with 
difficulty to a pharmacological effector site. Furthermore 
the pharmacological effect of a drug usually depends on a 
32 
well defined molecular structure . Conjugation with glucu-
11 
ronic acid obviously causes an extensive alteration in this 
structure, resulting in bioinactivation. 
In vivo, the efficiency of glucuronidation as a means of 
bioinactivation, is strongly influenced by the action of 
^-glucuronidase. The action of g-glucuronidase in the intes-
tine, for example, causes that some drugs enter an entero-
hepatic circulation which impairs their disposition. Thus, 
chloramphenicol glucuronide is deconjugated in the intestine 
and the released parent compound is further metabolized to 
toxic arylamines, which are reabsorbed into the circula-
tion33. 
The glucuronidation of the carcinogenic metabolite of 2-naph-
thylamine, 2-amino-l-naphthol, is an example of an adverse 
effect of this type of conjugation. The glucuronide of this 
metabolite is excreted in the urinary tract, where it after 
34 deconjugation in the bladder, can cause bladder cancer 
UDPglucuronyltransferasej a membrane-bound enzyme 
Uridine diphosphate glucuronate glucuronyltransferase (EC 2. 
4.1.17) is located in the endoplasmic reticulum of the liver 
cell . It is also present in kidney cortex, gastrointestinal 
mucosa, epidermis and adrenal tissue. But the activity in the-
Ifì IS iß "47 
se tissues is low compared with the liver ' ' ' . A ste 
roid glucuronyltransferase was found in the outer mitochon-
s oJ 
.39 
36 3
-
i 
38 drial membrane f pig intestine and in the cytosol fraction 
of human liver" 
UDPglucuronyltransferase is bound to the microsomal membranes 
and there are indications that it is located on the inside of 
40 41 42 
the microsomal vesicles ' ' . After treatment of microso-
mal preparations with ultrasonication, deoxycholate, digito-
nin, lubrol or snake venom the enzyme stayed in the superna-
tant of a 100,000 χ g centrifugation 4 3' 4 4' 4 5' 4 e' 4 7. Morpholo­
gical investigation of these so-called solubilized prepara­
li 
43 44 tions, showed that they contained membrane fragments ' 
Preparations not containing these fragments were devoid of 
43 
enzyme activity . Thus extraction of UDPglucuronyltransfe-
rase from the microsomal membranes apparently results in 
loss of enzyme activity. 
The activity of UDPglucuronyltransferase, in vitro, is 
greatly influenced by treatment of the microsomes with mem­
brane perturbating agents. Triton X-100 ' ' , low concen­
trations of deoxycholate 4 4 ' 4 8 ' 5 1 digitonin45'52, lubrol46, 
53 54 
tween and ultrasonication enhanced the enzyme activity. 
Higher activities were also measured after storage of the 
preparations for several days at О С or when the homogeni-
zation medium contained KCl instead of sucrose ' . In ad­
dition, an increase in enzyme activity was observed after a 
short treatment of microsomal preparations with phospholi-
pase A but this occurred at the expense of the stability 
of the enzyme 
Many functions of UDPglucuronyltransferase seem to depend on 
the integrity of the enzyme-membrane relationship. In native 
microsomes for example, UDPglucose, UDPxylose, UDPmannose 
and UDPgalactose do not interact with the UDPglucuronic acid 
binding site on the enzyme, but in phospholipase A treated 
microsomes they inhibit the binding of UDPglucuronic acid 
Furthermore stimulation of the enzyme by UDP-N-acetylgluco-
samine was only found in native microsomes. 
UDP-N-acetylglucosamine caused inhibition of the enzyme ac­
tivity in phospholipase A treated preparations . Also the 
interaction of sulfhydryl reagents with the enzyme was dif­
ferent in native and phospholipase A treated preparations. 
Sulfhydryl reagents stimulated the enzyme in a characteris­
tic way in native microsomes, they inhibited the enzyme in 
58 phospholipase A treated preparations 
The effect of UDP-N-acetylglucosamine on the glucuronyl-
13 
transferase activity in native microsomes is probably media­
ted by an allosteric mechanism. UDP-N-acetylglucosamine en­
hances the rate of glucuronidation and increases the affini­
ty for UDPglucuronic acid ' . This effect only occurs in 
the presence of divalent metal ions ' and could be com­
pletely blocked by sulfhydryl reagents . Several glucuroni-
des also may act as allosteric affectors of the enzyme. The 
glucuronides of 1-naphthol, 2-naphth.ol and ^methylumbelli-
ferone stimulate the synthesis of p-nitrophenolglucuronide 
and increase the affinity for UDPglucuronic acid. p-Nitro-
phenol glucuronide had a similar effect on the glucuronida­
tion of 1-naphthol, o-naphthol, o-aminobenzoate and biliru-
bin . These studies were done with native microsomes from 
guinea pig liver. 
Other authors found that in digitonin treated rat liver mi­
crosomes, 1-naphtholglucuronide inhibits the glucuronidation 
of p-nitrophenol and competes with UDPglucuronic acid in 
this reaction . Thus the allosteric effector site is proba­
bly sensitive to membrane perturbating agents. It is also 
possible that only in detergent treated microsomes glucuro­
nides have free access to the UDPglucuronic acid binding 
site. 
Js lipid required for UDPgluouronyltransferase funotion ? 
Prolonged treatment of microsomes with phospholipase A or С 
led to inactivation of the p-nitrophenol glucuronidating 
64 
form of UDPglucuronyltransferase . Products of phospholi­
pase action - fatty acids, lysolecithin, diglyceride and 
phosphorylcholine - were not inhibitory . The activity of 
the phospholipase A treated preparation could be completely 
restored by addition of mixed phospholipid micelles or phos-
m с 
,64 
phatidylcholine but the restoration of the phospholipase С 
treated preparation was only partial 
14 
For the steroid gLucuxonidation the reports are contradic­
tory. Treatment of a solubilized preparation from human li­
ver microsomes with phospholipase С Led to inactivation of 
16a-oestriol glucuronyltransferase. Lysolecithin, but not 
68 
e.g. lecithin, partially restorted the activity . Steroid 
glucuronyltransferase of rabbit liver microsomes was only 
partially affected by treatment with ánake venom and phos-
pholipids only partially reactivated the preparation. Phos-
pholipase С had no effect 
The following criteria should be obeyed to determine if an 
enzyme requires lipid for correct function: 
1. correlation between loss of enzymatic activity and al­
teration or removal of lipid; 
2. restoration of activity with addition of lipid; and 
3. restoration of activity should be correlated with bin-
ding of the lipid to the enzyme 
The latter demand can of course only be verified in work. 
with purified enzymes. Microsomal enzymes complying with 
these criteria are glucose 6-phosphatase, NADH cytochrome b_ 
reductase and the microsomal cytochrome P-450 linked hydro-
6 9 70 1 2 3 
xylating system ' ' ' ' . Phosphatidylcholine is specifi­
cally required by the reduction of cytochrome P-450 . The 
former two enzymes require phosphatidylethanolamine and 
phosphatidylcholine, respectively ' . The enzyme mediating 
the glucuronidation of p-nitrolphenol also complies with the 
above mentioned criteria. Whether all possible forms of UDP-
glucuronyltransferase require lipid for correct function has 
not been proven yet. 
Heterogeneity of UDPgluauronyltransferase 
A wide variety of compounds can serve as substrates for UDP-
glucuronyltransferase. Steroid hormones, thyroxine and deri­
vatives, catecholamine metabolites, bilirubin and a great 
15 
many foreign compounds are conjugated with glucuronic acid 
before they are suitable acceptor groups for glucuronyl 
transfer ' ' . The question whether only one aspecific 
enzyme is responsible for the glucuronidation of these com-
pounds or whether UDPglucuronyltransferase is in fact a 
group of different enzymes, has been extensivily investiga-
ted in recent years. 
Steroids are glucuronidated with a high degree of specifici-
78 ty . Studies on the glucuronidation of oestriol have shown 
that the glucuronyl group was attached to the 3a-0H of this 
79 
oestrogen when guinea pig liver was used as enzyme source 
but with preparations from mouse or human liver the 16a-glu-
39 80 81 
curonide was formed ' ' .In these studies it was also 
found that the steroid glucuronyltransferase from guinea pig 
liver does not accept oestriol 16-monoglucuronide as sub-
go 
strate . With mouse liver, however, both unconjugated oes-
triol as well as oestriol 3-monoglucuronide were substrates 
82 for glucuronidation . Furthermore differences in pH optima 
for different steroid glucuronidations have been reported. 
Human gut, for example, contains a glucuronyltransferase for 
the glucuronidation of oestriol, oestradiol and testosterone 
83 
at the 17ß-OH with a pH optimum of pH 6.6 . The formation 
of oestriol Іба-monoglucuronide, oestriol 3-monoglucuronide 
and oestradiol 3-monoglucuronide however, occurs optimally 
39 78 
around pH 8.2 ' . These results suggest that different 
steroid glucuronyltransferase exist. The role of these en­
zymes, if any, by the glucuronidation of non-steroid com­
pounds is not clear. 
The homozygous Gunn rat cannot dispose of its bilirubin be­
cause of an autosomal recessive deficiency of the bilirubin 
glucuronidating enzyme. Studies with this animal revealed 
that bilirubin glucuronyltransferase is probably a separate 
entity which differs from the enzymes involved in the syn­
thesis of N-glucuronides, glucuronides of several phenolic 
16 
Substrates, acyl glucuronides, the glucuronides of thyroxine 
05 86 87 
and derivatives and tetrahydrocortisol glucuronide ' ' ' 
88,89,90,91,92_
 I n c o r l t r a s t t o bilirubin glucuronide these 
latter glucuronides can be formed in the Gunn rat in vivo, 
or with preparations from the liver of this animal. The 
disease of the Gunn rat is not confined however to an inabi­
lity to glucuronidate bilirubin as also relatively low acti­
vities were measured by the glucuronidation of some other 
substrates. The glucuronidation of these substrates, however, 
could be enhanced to a normal level by pretreatment of the 
go q л 
enzyme preparations with diethylnitrosamine ' . An expla­
nation for this phenomenon may be that normally the glucuro­
nidation of these substrates is mediated by the bilirubin 
glucuronyltransferase, but by deficiency of this enzyme, are 
glucuronidated by other non-deficient enzymes. These other 
enzymes apparently do not accept bilirubin as substrate. 
Accumulation of bilirubin in Gunn rats may cause several ad­
ditional defects in the liver cell which lead to alterations 
in the endoplasmic reticulum membrane. 
Microsomal membrane preparations from Gunn rats differ from 
88 
normal rats in that they react differently with detergents 
Possibly, related to this, it was also found that the micro-
93 
somal drug oxidation is disturbed in these animals 
The glucuronidation of foreign substrates may be mediated by 
special enzymes or by forms of UDPglucuronyltransferase for 
which endogenous compounds are the physiological substrates. 
From an evolutionary point of view, the latter possibility 
seems more likely. This problem has been approached by' stu­
dying inhibition kinetics with alternative substrates or 
Q4 Q^ Qfi Q7 Qft 
products as inhibitors ' ' ' ' . It has been reported 
however, that the glucuronidation of several substrates is 
not according to simple enzyme kinetics. For example, con­
cave Lineweaver Burk plots were found by the glucuronidation 
of p-nitrophenol and o-aminophenol which may indicate nega-
17 
59 99 tive cooperativity by the binding of UDPglucuronic acid ' . 
Substrate inhibition was found by the glucuronidation of phe-
98 
nolphthalein . Furthermore unexpected interactions may oc-
cur by studies on glucuronidation in the presence of alter-
native substrates. It has for example been reported that the 
time course for the formation of o-aminophenol glucuronide 
shows, a distinct upward bend, in the presence of p-nitro-
98 phenol . These problems complicate kinetic studies, and the 
reports are contradictory (compare 94 and 98). 
Furthermore the specificity of possible different enzymes 
may not be absolute for foreign substrates and this also li-
mits the value of these studies. The most convincing evi-
dence with regard to foreign substrates comes from solubili-
sation studies. Treatment of rabbit liver microsomes with 
snake venom resulted in a soluble fraction with activity for 
the formation of p-nitrophenol and anthranilic acid glucuro-
nide, whereas the glucuronidation of aniline remained confi-
ned to the insoluble fraction , suggesting multiplicity of 
UDPglucuronyltransferase. 
Also the mutual interference by the glucuronidation of fo-
reign substrates and bilirubin has been studied extensive-
ly101,102,103,104,105_ T h e i n t e r p r e t a t i o n o f these studies 
however, is complicated by the following points : 
a. Bilirubin is insoluble at pH's generally regarded as op-
io fi 
timal for glucuronidation of foreign substrates . There-
fore albumin is used to keep bilirubin in solution ' ' 
but in the presence of albumin kinetic data are hard to eva-
84 109 luate and non-linear Lineweaver Burk plots are found ' ' 
110
. 
b. Bilirubin binds to lipids and membrane ' ' and 
therefore true substrate concentrations are difficult to 
calculate. 
c. Bilirubin has a detergent-like effect on microsomal mem-
branes, it activates native microsomes and inhibits activa-
is 
114 
ted preparations . Also in these studies contradictory re­
sults have been reported (compare 104 and 1051 » and no con­
clusive evidence has been obtained about the role of biliru­
bin glucuronyltransferase in the metabolism of foreign sub­
strates. 
Bilirubin gluauronidation 
Bilirubin IXa is the physiological breakdown product of heme. 
Its systemic name is 1'8'-dioxo-l,3,6,7-tetramethyl-2,8,-di-
vinylbiladiene-(a,c)-dipropionic acid-(4,5) 
Bilirubin is a lipophilic compound and is insoluble in wa­
ter below pH 7.8 - pH 8.0 1 0 6. The pKa of the carboxyls is 
7.8 . Bilirubin readily oxidizes to biliverdin, monopyr-
117 
roles and dipyrroles . Unconjugated bilirubin is internal­
ly stabilized by probably four hydrogen bonds between the 
carboxyls and the exo pyrrolenone rings in both halfs of the 
1 1 fi 1 1 9 
molecule ' . Esterification of the carboxyls of the pro­
pionic acid side chains breaks up these bonds and causes 
119 
that the bilirubin conjugates are extremely labile . There­
fore most authors studied the azoderivatives of these conju­
gates rather than the parent compounds ' . By the analy­
sis of mixtures containing different sugar conjugates this 
causes the problem of reconstruction of the original tetra-
pyrrole structures from a mixture of different azodipyrroles. 
This problem does not exist by in vitro work whereby one 
deals with only one conjugating group. 
In contrast to the traditionally held view that bilirubin is 
mainly excreted as a diglucuronide , it was recently found 
122 123 that a fraction of human T-tube bile ' and bile from 
Т О Л T ^ T Л О A 
dogs ' 1' 1 ¿ , alligators, cats, chickens, horses, opos-
sums, rabbits and snakes125 consist of alkali-labile, glucu-
ronidase-resistent sugar conjugates, which could be identi-
fied as xylosyl and glucosyl conjugates. Furthermore glucu-
ronosyl-glucosyl, glucuronosyl-glucuronosyl and glucosyl-
19 
126 
glucuronosyl conjugates were found and characterized . In 
122 123 
all studies both, mono- and diconjugates were found ' ' 
' ' ' .In vitro, xylosyl and glucosyl conjugates 
are formed on incubation of bilirubin with UDPxylose or UDP-
glucose and preparations from the livers of rats, cats or 
. 15,16,125 horses ' ' 
Conjugation is an absolute requirement for the disposition of 
bilirubin. A complete deficiency of the bilirubin conjugating 
system is a serious inborn error of metabolism (Crigler Naj­
jar, type Ij. Patients with this disease usually die in the 
1 2Й first decade of life, with severe brain damage . None of 
the above mentioned conjugates is formed in these patients 
129 
20 
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PLAN AND INTENT OF STUDY 
The glucuronyl conjugation is the subject of this study. In 
particular the question whether UDPglucuronyltransferase is 
one enzyme, catalyzing the glucuronidation of many different 
compounds, or a multiplicity of enzymes, catalyzing more or 
less specific reactions, was investigated. 
In paper I, the glucuronidation of different substrates was 
studied before and after treatment of the test-animals with 
phénobarbital, for different periods of time. The assump-
tion was made that if the glucuronidation of p-nitrophenol 
and bilirubin is mediated by different enzymes, their res-
ponse to the inducing effect phenolbarbital may be diffe-
rent. Although it is known that the effect of treatment 
with phénobarbital on the metabolism in the liver cell is 
specific in that it increase the total amount of drug meta-
bolizing smooth endoplasmic reticulum, on the other hand in-
duction of some enzymes is more rapidly achieved than of 
others . This probably depends on differences in turnover 
rates of the enzyme proteins and on differences at the re-
gulatory level. Animals were choosen which are known extre-
mes for the glucuronidation of the studied compounds. 
The papers II, III and IV deal with the bilirubin glucuroni-
dating form of UDPglucuronyltransferase. Bilirubin and bi-
lirubin monoglucuronide are both physiological substrates 
for glucuronidation, and may be specific substrates for cer-
tain forms of UDPglucuronyltransferase. In view of the great 
specificity found by the glucuronidation of steroids, it 
seemed worthwhile to study these two endogenous substrates. 
The glucuronidation of bilirubin monoglucuronide, in vitro, 
has not been studied before. 
Paper V reports on the solubilization, delipidation and re-
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Constitution of UDPglucuronyltransferase. The hypothesis of 
this study was that solubilization of the enzyme-protein 
from the microsomal membranes may result in an inactive pre-
paration. Reconstitution of the enzyme with detergents or 
phospholipids was thought to be an essential step by its pu-
rification. 
Publications : 
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the study of the liver, Arnhem, september 19 72. 
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INFLUENCE OF PHENOBARBITAL TREATMENT ON 
/7-NITROPHENOL AND BILIRUBIN GLUCURONIDATION 
IN WISTAR RAT, GUNN RAT AND CAT 
Ρ L. M. J A N S E N and P. T H . H E N D E R S O N 
Institute of Pharmacology, Faculty of Medicine, University of Nijmegen, Nijmegen, 
The Netherlands 
(Received 22 March 1972, accepted 18 April 1972) 
Abstract—The influence of phénobarbital pretreatment on the glucuromdation of 
p-mtrophenol and bilirubin has been compared in liver microsomes from Wistar rat, 
homozygous and heterozygous Gunn rat and cat Both for Wistar rat and cat it 
appeared that phénobarbital has a different effect on />-nitrophenol and bilirubin 
glucuromdation No bilirubin glucuromdatmg activity could be detected in homozygous 
Gunn rats both before and after exposuie to phénobarbital Thep-nilrophenol glucuron-
idating capacity of Gunn rats, however, was strongly enhanced after phénobarbital 
treatment. These results are arguments in favour of the involvement of different enzymes 
in the glucuromdation of p-mtrophenol and bilirubin 
UDPGLUCURONYLTRANSFERASE (UPDglucuronate glucuronyltransferase, EC 2 4 I 17, 
acceptor unspecific) catalyzes the transfer of the glucuronyl group from glucuronic 
acid to aglycones. Ether-, ester-, N- and S-glucuromdes are thus formed. 
There are many indications that UDPglucuronyltransferase consists of a hetero-
geneous group cf enzymes Homozygous Gunn rats, for instance, although deficient 
in bilirubin glucuromdation, have a normal glucuromdatmg capacity towards ^-nitro-
phenol, aniline and tetrahydrocortisone. The cat, however, has been reported to have 
a normal bilirubin metabolism accompanied by a poor capacity to glucuromdate 
/7-nitrophenol, menthol and o-aminophenol (summarized by Dutton') In this study 
Wistar rats, homozygous and heterozygous Gunn rats and cats were treated with 
phénobarbital The effect of this treatment on the in vitro activity of UDPglucuronyl-
transferase, with /vnitrophenol and bilirubin as substrates, has been studied 
It is known that treatment with phénobarbital stimulates liver growth and increases 
the amount of microsomal protein in the liver 2 In order to differentiate between these 
effects and those on the /vnitrophenol and bilirubin glucuromdation, an increase of 
specific activity was considered to be a prerequisite for enzyme induction 
Mulder3 and Winsnes4 ha\e reported that phénobarbital does not stimulate 
/7-nitrophenol glucuromdation unless activated enzyme preparations are used In 
this investigation microsomes were activated with ultrasonic vibration which has a 
similar effect as Triton X-100, used by the latter authors s 
METHODS 
Animais. Male Wistar and Gunn rats, 3-4 months old, weighing about 250 g, and 
male cats, approx 1 year old, weighing about 2500 g were used. 
Gunn rats were obtained from the University of California m 1958 and bred in our 
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Animal Laboratory. Icteric homozygous males were mated with nonicteric hetero-
zygous females. 
Phénobarbital treatment. Wistar and Gunn rats were treated daily with 75 mg and 
cats with 40 mg phenobarbital/kg body wt. for 6 days. 
Wistar rats and cats treated for 12 days successively received daily 20 mg/kg for 
3 days, 30 mg/kg for 3 days and 40 mg/kg for 6 days. The Gunn rats received daily, 
75 mg phenobarbital/kg body wt. for 12 days. Control animals received saline. The 
animals were injected intraperitoneally, once daily at 9 a.m. Enzyme activities were 
determined 24 hr after the last injection. 
Preparation of microsomes. The rats were killed by stunning and decapitation, the 
cats by injecting 4 ml sodium pentobarbital (6 per cent) into the heart, immediately 
followed by decapitation. After the animals were exsanguinated the livers were 
excised, weighed and kept in ice. 
Portions of the livers were weighed, finely minced and transferred into 4 vol. of an 
ice-cold 0-25 M sucrose solution, containing 10"3 M sodium ethylenediamine tetra-
acetate (EDTA-Na) and 5 X 10_ 2M tris(hydroxymethyl)aminomethane-HCl 
buffer (pH 7-4). 
Homogenates of rat liver were prepared using a Teflon-glass Potter-Elvehjem 
homogenizer. Cat liver was homogenized with an Ultra-Turrax apparatus. 
Microsomal fractions were obtained by centrifuging the homogenates at 9000 g in 
an IEC B-20 centrifuge at 2° for 20 min. The 9000 g supernatants were centrifuged 
at 105,000g in a Christ Omega II ultracentrifuge at 2° for 1 hr. The pellets from the 
latter step were gently resuspended in the homogenization medium with the Potter-
Elvehjem apparatus. One ml suspension contained microsomes derived from 1 g 
liver. 
The suspensions were treated with an ultrasonic distintegrator (MSE-100 Watt) for 
6 χ 10 sec, at maximal output. 
Chemicals. Bilirubin, ascorbic acid, sulfanilic acid and sodium nitrate were obtained 
from Merck A. G., Germany; p-nitrophenol from the British Drug Houses Ltd., 
England; the disodium salt of UDPglucuronate from C. F. Boehringer, Germany. 
Bovine serum albumin was obtained from Poviet, The Netherlands. 
Enzyme assay. Bilirubin was dissolved in calcium-free Tyrode buffer (pH 9-0). The 
incubation system consisted of: 0-30 ml microsomal preparation, 0-80 ml Tris-HCl 
buffer (005 M, pH 7-4), 015 ml UDPglucuronate (6 χ ΙΟ" 3 M, final cone), 0-05 ml 
MgCl2 (3-3 X lO- 'M, final cone.) and 020 ml bilirubin (20-80 χ ΙΟ" 6 M, final 
cone). The products were assayed according to the method described by Lathe and 
Walker6 using diazolized sulphanilic acid as the diazo reagent. Blanks containing 
all above mentioned ingredients, except UDPglucuronate, were submitted to exactly 
the same diazo procedure as the reagent mixtures. 
The/7-nitrophenol incubation system consisted of: 0Ό5 ml microsomal preparation, 
0-10 ml MgCl2 (0-5 X I O - 3 M, final cone), 005 ml UDPglucuronate (6 X I O - 3 M, 
final cone) and 0·05 ml p-nitrophenol (0-5-6 Χ 10 - 3 M, final cone) and the reagents 
were dissolved in Tris-HCl buffer (0-05 M, pH 7-4). The assay was done as described 
by Henderson and Kersten.7 The reaction mixtures were incubated at 37° for 30 min. 
Protein determination. Protein was determined by the method of Lowry et al.9 with 
bovine serum albumin as reference. 
Calculations. Kinetic data were analysed using Lineweaver-Burk plots. Michaelis-
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Menten constants (Km) are called apparent because crude microsomal preparations 
were used. Maximal substrate turnover rates per mg microsomal protein (/mai) were 
calculated by extrapolation. Statistical analysis was done with Student's Mest. 
RESULTS 
The results are summarized in Fig. 1 and Table 1. We ascertained that rates of 
conversion for both p-nitrophenol and bilirubin remained unchanged during the 
incubation period. 
Wistar rats. p-Nitrophenol glucuronidation appeared to be induced after a 6 day 
treatment with high doses phénobarbital whereas no induction of the bilirubin 
glucuronidation was found. Both p-nitrophenol and bilirubin glucuronidation were 
induced after a 12 day treatment with low doses phénobarbital. 
Concomitant with increased ¿„„„-values apparent ^„-values were also increased 
(Fig. 1). 
Nitrophenol -
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for 12 days 
FIG. 1. Influence of phénobarbital treatment upon apparent Km and r„„ of p-nitrophenol and bili-
rubin glucuronidation in Wistar rat, homozygous and heterozygous Gunn rat and cat. 
The number of animals and dosage are described in Table 1. Blocks represent means ^ S.E. 
* Ρ < 0-05 (Student's Mest), f™ and K„ are expressed as nmoles/hr per mg protein and mM 
respectively. 
Increments of microsomal protein were found after phénobarbital treatment but 
liver wt./body wt. ratio was not changed (Table I). 
Homozygous Gunn rats. A total deficiency in the glucuronidation of bilirubin was 
found together with high activities for the glucuronidation of p-nitrophenol. After 
6 and 12 days phénobarbital treatment the /„,„ for the glucuronidation of p-nitro-
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T A B L E I . I N F L U E N C E O F P H É N O B A R B I T A L T R E A T M E N T O N M I C R O S O M A L P R O T E I N A N D L i v t n W T / B O D Y W T . 
RATIO IN WlSTAR RAT, GUNN RAT AND CAT 
Wistar rat 
Homozygous Gunn 
rat 
Heterozygous Gunn 
rat 
Cat 
Days treated with 
phénobarbital* 
Control 
6 
12 
Control 
6 
12 
Control 
12 
Control 
6 
12 
л 
6 
6 
6 
6 
6 
6 
7 
4 
6 
3 
3 
Microsomal proteint 
(mg/g wet liver wt ) 
22 9 i 0 7 
26 4 ± 0 9§ 
25 8 ± 0 4 § 
18 1 f 1 3 
255 ± 2 1§ 
26 6 + 1 8§ 
188 t 10 
198 1- 1 7 
125 ^ 1 3 
153 ± 2 7 
1 3 4 _ L 0 8 
Liver wt 
Body wt X , 0 0 t 
4 3 rcOS 
5 0 ± 0 5 
5 1 ± 0 5 
4 0 a _ 0 7 
5 4 ± 0 9 
4 5 ± 0 5 
3 7 + 0 3 
3 9 ± 0 4 
3 0 ± 0 3 
3 3 ± 1 2 
4 2 ± 0 3 t 
* Wistar rats and homozygous Gunn rats were treated daily with 75 mg phenobarbilal/kg body 
wt for 6 days; cats with 40 mg/kg for 6 days Wistar rats and cats treated for 12 days received daily, 
successively, 20 mg/kg for 3 days, 30 mg/kg for 3 days and 40 mg/kg for 6 days The Gunn rats 
received daily 75 mgikg for 12 days Control animals received salme 
η, number of animals in each group. 
t means — S.E 
tOOl < Ρ < 005 
§P < 001. 
phenol amounted respectively to about 450 and 200 percent of the control value. The 
same pattern was observed for the apparent K
m
-va\ue (Fig. 1). 
The influence of phénobarbital treatment upon microsomal protein and liver wt./ 
body wt. ratio was the same as found for the Wistar rat (Table I). 
Heterozygous Gunn rais. The /„„-values of both p-mtrophenol and bilirubin 
glucuromdation were enhanced after 12 days treatment with phénobarbital but only 
the apparent K„ for the bilirubin glucuromdation was concomitantly increased 
(Fig. 1). Neither microsomal protein nor liver wt /body wt ratio were increased after 
phénobarbital treatment (Table I). 
Cats /»-Nitrophenol glucuromdation could not be induced by phénobarbital treat-
ment. The /„„-value of the bilirubin glucuromdation was increased after a 12 day 
phénobarbital treatment whereas no induction was found after 6 days. In both cases 
phénobarbital treatment did not result in increased apparent /^-values 
Phénobarbital treatment had no influence on the microsomal protein of cat liver. 
Liver wt./body wt. ratio was increased only after 12 days (Table 1). 
DISCUSSION 
The question whether or not UDPglucuronyltransferasc is one enzyme has never 
definitely been resolved Mulder' and Storey10 studying the competition between 
several aglycones, like^-mtrophenol, o-ammophenol, Phenolphthalein and anthramhc 
acid, came to contradictory conclusions. Assuming the existence of several glucuro-
nyltransferases however, these enzymes might be quite unspecific towards these 
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Substrates. Tomlinson and YafTe" and Halac and Reff12 tried to solubilize glucuro-
nyltransferase from crude liver microsomes with detergents and reported that different 
results were obtained with p-nitrophenol and bilirubin as substrates. Moreover a 
different post-natal development11 and a different behaviour towards heat denatura-
tion12 was found with these two substrates. 
In the present study it is shown that the hereditary lack of the bilirubin glucuroni-
dation enzyme of the homozygous Gunn rat is total. This is at variance with the 
data of other authors14 who reported low activities in these animals In contrast 
the p-nitrophenol glucuronidating activity was not deficient. This is in agreement with 
the results of Van Leusden et al ,13 who used Gunn rats of the same breeding colony. 
The p-nitrophenol-glucuromdating capacity of the homozygous Gunn rats increased 
strongly after phénobarbital treatment. It appeared that the p-nitrophenol-glucuro· 
nidating enzyme does not accept bilirubin as a substrate since no bilirubin glucuroni-
dation was found after 6 days of phénobarbital treatment whereas the amount of 
p-nitrophenol-glucuronidatmg enzyme was abundant. This pleads for the existence of 
a separate bilirubin-glucuronidating enzyme-system which is lacking in the homozy-
gous Gunn rat. This bilirubin-glucuronidating enzyme must also be different from 
the enzyme(s) glucuronidating aniline, tetrahydrocortisone, o-aminophenol, phenol-
dibromphthalein and diphenylacetic acid, in which the homozygous Gunn rat is not 
deficient.15-18 
p-Nitrophenol and bilirubin glucuronidation were influenced differently by phéno-
barbital, both in Wistar rat and cat. In the Wistar rat p-mlrophenol glucuronidation 
was induced after a 6 day treatment with high doses, whereas bilirubin glucuronida-
tion was only found to be induced after a 12 day treatment. This was achieved with 
relatively low doses phénobarbital. 
Our finding that p-nitrophenol glucuronidation is elevated in rats after a short treat-
ment with high doses phénobarbital is in agreement with the results of Mulder 3 As far 
as bilirubin glucuronidation is concerned, Pilcher et al19 reported that induction was 
only found after treating rats for a long period with high doses phénobarbital whereas 
no increase was found after treatment for a short period. These authors however 
found a decreased specific activity for the bilirubin glucuronidation after 30 mg 
phenobarbital/kg for 10 days As they used for the m utio assay albumin as a carrier 
for bilirubin the effective substrate concentration might have been much lower than 
the calculated one, due to the strong binding of bilirubin to albumin.20 A rise in 
apparent Km after phénobarbital treatment might then explain their results. 
In the cal phenobarbit il treatment did not effect p-mtrophenol glucuronidation nor 
rrkrosomal protein whereas bilirubin glucuronidation was induced Compared with 
the Wistar rat, />-nitrophenol glucuronidation by the cat appears to be less efficient: 
beside an equal f1Ilax a remarkabl> higher apparent Km was found for the glucuronida-
tion of this compound in the cat This might explain the absence of glucuromdes in 
the urine of cats after injection of glucuromdogenic compounds 2I Presumably in 
the c?t glucuronidation is not a preferential pathway for the elimination of foreign 
compounds 
These distinct effects of phénobarbital on the glucuronidation of p-nitrophenol 
and b.lirubm in both Wistar rat and cat add to the evidence that p-mtrophenol and 
bilirubin are glucuromdated by different enzymes. Compared with the influence of 
phénobarbital treatment on the microsomal ox>dati\e enzymes,2 p-mtrophenol 
35 
glucuronidation and microsomal protein,2 the induction of the bihrubin-glucuroni-
dating enzyme is a slow effect The question arises whether this is still a direct effect 
of phénobarbital treatment or rather some secondary effect It is known that bilirubin 
production is increased after phénobarbital treatment 22 Prolonged exposure to a 
higher bilirubin level might induce the bihrubin-glucuromdating enzyme, as was 
found m newborn rats 23 
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Mono- and diglucuronidation of bilirubin 
P L. M JANSEN 
UDPglucuronyl transferase in the endoplasmic 
reticulum of the liver cell catalyses the transfer 
of the glucuronyl group from UDPglucuromc 
acid to physiological compounds such as bili-
rubin, thyroxine, adrenaline and steroid hor-
mones, and also to many compounds foreign to 
the organism, eg drugs There are many in-
dications that UDPglucuronyl transferase con-
sists of à heterogeneous group of enzymes4 
The homozygous Gunn rat isjaundiced because 
it is unable to glucuromdate bilirubin, on the 
other hand, many other compounds are reported 
to be glucuromdated by this animal*. Bilirubin 
glucuronyl transferase must therefore be different 
from the glucuromdating enzymes for which the 
Gunn rat is not deficient, and which presumably 
do not accept bilirubin as a substrate Bilirubin 
was therefore chosen as substrate in our study 
on glucuromdation processes in the liver. 
Since in bile bilirubin appears mainly conju-
gated with two glucuronic acid molecules'·', we 
exammed how this diglucuronide is formed en-
zymatically It was found that, in vitro, the two 
glucuronyl groups are attached to the bilirubin 
molecule m two steps first, bilirubin monoglu-
curonide is formed and subsequently bilirubin 
monoglucuronide is conjugated to bilirubin 
diglucuronide Whether these two steps are 
mediated by one or two enzymes was studied 
by investigating the glucuromdation of bilirubin 
or bilirubin monoglucuronide in the presence of 
p-mtrophenol, which is a good substrate for 
glucuromdation 
METHODS 
Chemicals - Triton X-loo was obtained from 
BDH Chemicals Ltd, Poole, England, poly-
oxyethylene sorbitan monooleate (Tween 80) 
from Applied Science Laboratories Ine , State 
College, Pa , USA, deoxycholic acid sodium salt 
from Sigma, St Louis, Mo , USA, and Sephadex 
G-25 (coarse) from Pharmacia, Uppsala, Sweden 
Bilirubin was purchased from Merck A G. 
Germany, UDPglucuronate (disodium salt) from 
Boehrmger, Germany, p-nitrophenol from BDH 
Chemicals Ltd, England, and saccharo-i 4-
lactone from Calbiochem , Los Angeles, USA 
o-Ethylanthramlate came from Eastman Organic 
Chemicals, Rochester, Ν Y , USA, and bovine 
serum albumin from Poviet, Amsterdam, The 
Netherlands In thin-layer chromatography, pre-
coated silica gel plates, layer thickness о 25 mm, 
from Merck A G , Germany, were used 
Animals - Male cats, about 1 year old, and 
male Wistar rats, about 3 months old, were 
used 
Preparation of microsomes - 20% (wl/vol) 
Homogenates of cat and Wistar rat livers were 
prepared in 0 25 M suciose. ίο"3 M EDTA-Na, 
о 05 M Tris-HCl buffer (pH 7 8) After centri-
fugalion at 9000 g for 20 mm the supernatant 
fraction was centri fuged at 105,000 g for 1 hr 
Pellets were resuspended in the homogenization 
medium so that I ml suspension contained 
microsomes derived from 1 g liver Triton X-ioo 
(0 03%-1 7%, vol/vol) or Tween 80 (o 5%-? 5% 
vol/vol) was added to these microsomal suspen­
sions 
Solubilization of UDPglucuronyl transfeiase 
from cat liver microsomes - Microsomes were 
resuspended m о з% deoxycholale dissolved in 
the abovementioned homogenization medium 
After stirring for 4 hrs at 40C the suspension was 
centrifugedat 105,000 g for I hr The supernatant 
was passed over a column (16 χ looo mm) con­
taining Sephadex G-25 
Enzyme assays 
a Conversion of bilirubin to bilirubin mono- ana 
diglucuronide (B -* | BG + BG2|) - Reagent 
mixtures contained 200 μΙ bilirubin (aqueous 
solution), 200 μΐ UDPglucuronate, 200 μΙ enzyme 
and 600 μΐ Tris-HCl buffer (o 05 M, pH 8 3) 
containing MgCl2 (3 3 mM) and saccharo-i 4-
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lactone (ι mM) Final concentrations are men­
tioned in the legends ol' figures and Tables The 
assay was done as described by BLACK et al2 
The colour of the azopigment mixture, obtained 
after reaction of glucuronidated bilirubin with 
the diazonium salt of o-ethylanthranilate, was 
determined spectrophotometncally at 530 nm 
Conjugated bilirubin was calculated, assuming 
f6so 44 4 x io 3 VT'cm"1 (according to VAN ROY 
and HEIRWEGH12) 
b Conversion of bilirubin to diglucuromde (B -* 
BG -• |BG2 |) - The same assay and incubation 
system was used as mentioned under a The 
amount of diglucuromde was determined by 
applying a sample of the azopigment mixture 
directly to the silica gel plates Chromatograms 
were developed with chloroform methanol water 
(65 25 3, vol/vol/vol) Two clearly defined spots 
appeared in the a 0 and S region, representing 
azobihrubin and azobihrubin monoglucuronide, 
respectively" Diazotized rat bile was used as a 
reference. The spots were eluted in 1 ml methanol 
and the extinction was read at 530 nm in a Zeiss 
spectrophotometer PMQ H Freshly prepared 
blanks containing the reagents mentioned under 
a, except UDPglucuronate, were submitted to 
exactly the same diazo reaction as the reagent 
rruxlufes. Their chromatograms showed only a 
very faint diazo-positive line in the «„ region 
indicating that unconjugated bilirubin does not 
react with diazotized o-ethylanthranilate The 
following calculations were made % monoglu­
curonide = % a0 -t- % equimolar 8 — 2 χ % «„, 
% diglucuromde - % residual S = % S - % α 0 
(adapted from ref 11) 
c. Conversion of bilirubin monoglucuronide to 
diglucuromde (BG -» |ВО
г
|) - In a previous study 
Ц was found that after incubauon of Wistar rat 
liver microsomes with bilirubin and UDPglucu­
ronate (in low concentration), bilirubin mono­
glucuronide was formed in great excess' There­
fore an incubation system containing Wistar rat 
microsomes was used to generate bilirubin mono­
glucuronide This bilirubin monoglucuronide was 
then used as a substrate for incubation with 
solubilized enzyme derived from cat liver micro­
somes Incubation media used for the generation 
of bilirubin monoglucuronide contained 2 ml 
bilirubin (166 μΜ) 2 ml UDPglucuronate 
(2 mM), 2 ml with Triton X-100 (o 25", . vol'vol) 
pre-treated microsomes derived from Wistar rat 
liver, and Tris-HCl buffer (o 05 M, pH 8 3) con­
taining MgCl2 (3 3 mM) After incubation for 
30 mm at 37°C, bilirubin was extracted with 
chloroform The chloroform phase was discarded 
after centrifugation and the protein layer, which 
appeared to contain most of the bilirubin mono­
glucuronide, was suspended in the aqueous phase 
The amount of bilirubin monoglucuronide in this 
suspension was determined as described under b 
о 8 ml Monoglucuronide-contaming suspension 
was incubated with о 2 ml UDPglucuronate 
(3 mM) and о 2 ml solubilized enzyme prepara­
tion derived from cat liver for 25 mm at 37°C 
Bilirubin monoglucuronide and bilirubin diglu­
curomde were determined as described under b 
d p-Nitrophenol glucuromdation - The assay was 
according to HENDERSON and KERSTEN8 Incuba­
tions were done with the solubilized enzyme 
preparation at pH 8 3, m media containing 
MgCl2 (3 3 mM) 
Protein determination - Protein was determined 
by the method of JLOWRY rt al', with bovine 
serum albumin as referenc 
RESULTS 
Both bilirubin mono- and diglucuromde were 
formed when bilirubin and UDPglucuronate were 
incubated with microsomes derived from cat 
liver Besides Triton X-100, Tween 80 also 
appeared to activate microsomal bilirubin glucu­
romdation (Fig 1) With respect to the amount 
of bilirubin glucuronidated (thus the amount of 
monoglucuronide + diglucuromde formed) Tri­
ton and Tween were equally potent activating 
agents A greater fraction of glucuronidated 
bilirubin, however, was in the diglucuromde form 
when Tween was present in the incubation 
medium 
The effect of albumin on the glucuromdation 
of bilirubin is shown m Fig 2 Compared with 
the total amount of glucuronidated bilirubin, 
relatively less diglucuromde was formed when 
albumin was present in low concentrations 
(9 mg/ml) 
To study the enzyme kinetics of the formation 
of bilirubin mono- and diglucuromde, the glucu-
ronidaling enzyme system was solubilized from 
cat liver microsomes (Table 1) Glucuromdation 
38 
12 IA 16 18 
%tr,tonx-100( v /v) 4 6 θ 
Fig. ι. Influence of Triton X-ioo and Tween 8o on the conversion of bilirubin to bilirubin mono—t- diglucu-
ronide (B -* |BG + BG2I) and on the conversion of bilirubin to bilirubin diglucuronidc (B -» BG -» |BG,|). 
Reagent mixtures consisted of: 200 μΙ bilirubin (80 uM), 200 μΙ UDPglucuronate (5 mM), 200 ul microsomal 
suspension and 600 μΙ Tris-HCI buffer (0.05 M, pH 8.3) containing MgClj (3.3 mM) and saccharo-i.4-lactone 
(t mM). Detergents were added to the microsomal suspension 15 min prior to incubation. Detergent concen­
trations (abscissa) refer to the concentration in the miciosomal suspension. The ordinale represents nmoles 
product formed per g cat liver after 30 min. Determinations are described under a. and b. (Methods). 
TABLE I: SOU/BILIZATION OF BILIRUBIN GLUCURONYL TRANSFERASE FROM CAT LIVER 
Protein 
(mglml) 
В - \BG + BG,\* 
specific activity 
(nmoleslhr mg protein) 
BG -> |ДС
г
|»« 
specific aclmty 
(nmoleslhr mg protein) 
9000 g supernatant 
105,000 g supernatant 
105,000 g pellet 
Deoxycholate supernatant 
24.5 
19.5 
15.9 
14.0 
1.0 
4 0 
9.2 
2.5 
5.0 
* B-> |BG 4 BG
a
 I : Conversion of bilirubin to mono--I diglucuronide was determined as described under a. 
(see Methods). Reagent mixtures consisted of: 200 μ| bilirubin (166 μΜ), 200 μΐ UDPglucuronate (5 mM), 
200 μΐ enzyme preparation and 600 μΙ Tris-HCI buffer (0.05 M, pH 8.3) coniaining MgCl2 (3.3 mM) and 
saccharo-1.4-lactone (1 mM). Incubation for 30 mm at 370C. 
•"BG -* J BG,|: Conversion of bilirubin monoglucuronide to diglucuronidi.. Substrate was generated as described 
under c , and determined as described under b. (Methods). Reagent mixtures contained: 800 μΐ bilirubin 
monoglucuronide solution (25 μΜ), 200 μΙ UDPglucuronate (3 mM) and 200 μΐ enzyme preparation. Incu­
bation for 25 mm at 37°C. The amount of bilirubin diglucuronide was determined as described under b. 
(Methods). 
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пгтюіеэ per gram cat liver 
160 
120 
(¿jmoles/hpermg protein) . 
100-
20 24 26 
albumin [mg/ ml ) 
Fig. 2 Influence of albumin on (he conversion of 
bilirubin to bilirubin mono- L diglucuronide (B-» 
|BG + BG»!) and on the con\ ersion of bilirubin to bili-
rubin diglucuronide (B -» BG -» |BG2|) Reagent 
mixtures are described in the legend of Fig 1 Biliru-
bin concentration was in this experiment 166 uM 
Microsomes were pre-trcated with Triton X-ioo 
(i 2%, vol/vol) Abscissa albumin m final concentra-
tion, ordinate nmoles product formed per g cat liver 
after 30 min Determinations arc described under a 
and b (Methods) 
of bilirubin and of bilirubin monoglucuronide 
were studied separately Amounts of bilirubin 
glucuronidated and amounts of bilirubin mono-
glucuronide converted to diglucuronide increased 
linearly with time Velocities remained unchanged 
for 30 and 25 mm, respectively These conditions 
are prerequisites for en/ymc kinetic studies 
Velocities ol bilirubin glucuromdation measured 
over the range so-l6n uM bilirubin filled a 
straight line plotted double reciprocally according 
toLiNFWEAVfcR-BURK3(Fig 3) Michaelis Mcnlen 
conslant (K,,,) and maximal velocity (Vmds) 
amounted to 9 6 uM and 14 ч nmolcs/hr per mg 
protein In Fig 4 it is seen that velocities with 
which bilirubin diglucuronide was formed at 
80-
oO 
kO 
2 0 -
B—-JBg-fBfi^ ] 
Чпз* 133nmoles/h per mg protein 
Km 96MM 
12 16 20 (mM bil irubin) ' 
Fig 3 Glucuromdation of bilirubin (B-|BG |- BG2|i 
1/reaction velocity is plotted against 1/substrate con­
centration according to LINEWEAVER and BURK3 
Reagent mixture is described in the legend of Fig 1 
A solubilized enzyme preparation was used The 
determination is described under a (Methods) 
different bilirubin monoglucuronide concentra­
tions also fitted a straight line plotted according 
to LlNEWEAVER-BURK K
m
 13 8 μΜ, V
m a
, I5 
nmoles/hr per mg protein Measurements were 
made over the range 95-31 6 μΜ bilirubin mono­
glucuronide 
Bilirubin glucuromdation was not inhibited by 
p-mtrophenol (Table II) The conversion of 
bilirubin monoglucuronide to diglucuronide, 
however, was found to be inhibited m the 
presence of ^ -nitrophenol A DIXON plot1 of this 
inhibition shows it to be of the competitive type 
T A B L E I I I N F L U E N C E O F P - N I T K O P H E N O L O N T H E 
OLUCUKONIDATION Ot BILIRUBIN 
В - I BG+BGil Number of 
(nmoleslhr mg experiments 
piote η ± SD) 
Control 
-г 8 m M /"-nitrophenol 
9 2 ± 0 1 
94J-01 
Reagent mixtures consisted of 200 μΐ bilirubin (50 
uM), 200 μΐ UnPglucuronate (8 mM), 200 μΐ solubi­
lized enzyme and 600 μΐ Tns-HCl buffer (0 05 M, 
pH 8 3) containing MgCl2 (3 3 mM) p-Nitrophenol 
was added in a final concentration of 8 mM 
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Fig 4 Glucuronidalion of bilirubin monoglucuronide 
(BG-» IBG2I) LINEWEAVER-BURK plot A solubilizcd 
enzyme preparation was used For details see legend 
of Table I 
(Fig 5) with an inhibitor constant (K, ) of 
5 05 mM The K
m
-value of/7-nitrophenol glucu-
romdation found with this solubilized enz>me 
preparation from cat liver amounted to 4 80 m M 
(Vmax 250 nmoles/hr per mg protein) 
DISCUSSION 
Pre-treatment of microsomes with detergents such 
as Triton X-100 has been reported to activate 
glucuronidalion processes10 Detergents presum­
ably affect penetration barriers, in Ιΐκ microsomal 
environment, between substrate and active site 
It was seen that Tween 80 can also act as an 
activating agent In addition to this, another 
effect of Tween 80 was observed Relatively less 
monoglucuronide and more diglucuromde was 
found after incubation of bilirubin with Tween-
pretreated microsomes This effect of Tween 
shows that conversion of bilirubin mono- to 
diglucuromde should be distinguished from the 
conversion of bilirubin to bilirubin monoglucu­
ronide When bilirubin monoglucuronide de­
taches from the site where К was formed and 
must penetrate to the site where mono- is con­
verted to diglucuromde, Tween might exert its 
(¿imoleo/h per mg protein) 
Κ, Ί 0 -
4 2 0 2 4 6 θ 
ρ nitrophenot (mM) 
Fig 5 Influence of p-nitrophenol on the glucuroni­
dalion of bilirubin monoglucuronide (BG-» [ВО,!). 
DIXON plot3 1/reaction velocity is plotted against the 
inhibitor concentration Measurements were done at 
substrate concentrations of 207 μΜ and 31.6 μΜ 
bilirubin monoglucuronide UDPglucuronate con­
centration amounted to 5 mM A solubilized enzyme 
preparation was used For details see legend of Table I 
effect on penetration barriers in the vicinity of 
this second site Tween might also prevent that 
bilirubin monoglucuronide adheres to proteins 
and thus becomes unavailable as a substrate for 
the second step It was found that, when bilirubin 
was incubated with microsomes in the presence 
of albumin, relatively less diglucuromde and 
more monoglucuronide was formed In our in­
cubation system, therefore, albumin at low con­
centration (9 mg/ml) did not influence the con­
jugation of bilirubin to monoglucuronide, where­
as the conversion of mono- to diglucuromde was 
inhibited This adds further evidence that the 
conversion of bilirubin to bilirubin diglucuromde 
occurs in two distmct steps 
The question whether the two glucuronidalion 
steps are mediated by one or two enzymes was 
studied with a solubilized enzyme preparation. 
To study the two steps separately, both bilirubin 
and bilirubin monoglucuronide were used as 
substrates for glucuronidalion After incubation 
of bilirubin with UDPglucuronate and enzyme, 
both mono- and diglucuromde were formed. 
Assuming that diglucuromde can only be formed 
via monoglucuronide it seems justified to regard 
the velocity with which bilirubin is glucuromdated 
as equal to the velocity of monoglucuronide for-
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mation. The conversion of bilirubin ίο mono­
glucuronide and of bilirubin monoglucuronide 
to diglucuronide obeyed Michaelis Mcnten kine­
tics. Km- and V
ma
,-values for the two steps were 
found to be of the same order of magnitude. This 
is consistent with our finding that almost no 
bilirubin monoglucuronide was found in cat bile, 
whereas besides some other bilirubin conjugates, 
bilirubin diglucuronide was in excess7. 
In a previous study p-nitrophenol was shown 
to be glucuronidated with microsomes derived 
from cat liver*. In the present study we found 
that this compound inhibited the glucuronidation 
of bilirubin monoglucuronide competitively, 
whereas the conversion of bilirubin to mono­
glucuronide was not influenced. This is a strong 
indication that the two steps of bilirubin glucu­
ronidation are mediated by two different enzymes. 
Since the Ki-value of /7-nitrophenol for the 
glucuronidation of bilirubin monoglucuronide 
almost equals the K
m
-value for the glucuroni­
dation of/>-nitrophenol itself, the bilirubin mono-
glucuronide-glucuronidating enzyme might also 
be active in the glucuronidation of p-nitrophenol. 
Conclusion and clinical implications 
i. It was found that for the cat the activities of 
the proposed first- and second-step enzymes (the 
enzymes mediating the glucuronidation of bili­
rubin and the glucuronidation of bilirubin 
monoglucuronide, E, and E2, respectively) were 
of the same magnitude; hence for the cat 
E^Ej = i. In a previous study it was found that 
with microsomes derived from Wistar rat liver 
much more mono- than diglucuronide was 
formed, thus E,/E2 presumably > i. It depends 
on this ratio whether or not, in vivo, bilirubin 
monoglucuronide is formed under special circum­
stances. The findings of OSTROW and MURPHY11 
that in bile of rats infused with bilirubin more 
mono- than diglucuronide was found, is con­
sistent with our findings. A study on the Ε,/Ε,, 
ratio for human liver is in progress. 
2. Glucuronidation of drugs might be mediated 
by either Έ,ι or Έ%. When Km-values for the 
glucuronidation of drugs are of the same order 
of magnitude as the K
m
-value forp-nitrophenol 
glucuronidation, which appeared to be about 
350 χ that for bilirubin monoglucuronide glucu­
ronidation, only large amounts of drugs can 
inhibit step 1 or step 2 of bilirubin glucuronida­
tion. Bilirubin or bilirubin monoglucuronide, 
however, may be very effective inhibitors of 
glucuronidation of drugs by Ei or Ej, respect­
ively. 
3. The Crigler-Najjar syndromes (chronic non-
haemolytic unconjugated hypcrbilirubinaemia, 
with glucuronyl transferase deficiency) should be 
re-investigated. Since bilirubin is not glucuroni­
dated by the liver of patients with this deficiency, 
they probably lack E^ Whether they also lack 
E2 is not yet known. In this respect it is in­
teresting to know whether Е
г
 accepts bilirubin 
as substrate or not. According to ARIAS1, there 
are two types of the Crigler-Najjar syndrome: 
Type I, severe jaundice often with signs of 
kemicterus, no bilirubin glucuronide in bile and 
not responding to phénobarbital treatment; and 
Type II, moderate jaundice, some bilirubin 
glucuronide in bile and responding to phéno-
barbital treatment. The modes of inheritance of 
types I and II are different: Type I, autosomal 
recessive and Type II, probably autosomal 
dominant. Possibly in Type I both E! and E2, 
and in Type II only Et is lacking. 
SUMMARY 
Bilirubin glucuronidation was studied, in vitro, 
with cat liver microsomes. It was found that 
after incubation of bilirubin with microsomes 
pre-treated with Tween 80, relatively more 
diglucuronide and less monoglucuronide was 
formed than when incubations were done with 
untreated microsomes or with microsomes pre-
treated with Triton X-ioo. When bilirubin was 
incubated with microsomes in the presence of a 
small amount of albumin, relatively less diglucu-
ronide and more monoglucuronide was formed. 
From these results it was concluded that bilirubin 
is glucuronidated in two steps: first, bilirubin is 
conjugated with glucuronic acid to bilirubin 
monoglucuronide, and bilirubin monoglucuro-
nide is subsequently converted to diglucuronide. 
/>-Nitrophenol inhibited the second step com-
petitively, whereas the first step was not influenced 
by this aglycone. Hence the conclusion seems 
valid that the two bilirubin glucuronidation steps 
are mediated by separate enzymes. 
The Michaelis Menten constant (Km) of p-
nitrophenol glucuronidation and inhibitor con-
stant (K¡ ) of />-nitrophenol for the glucuronida-
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t ion of bilirubin monoglucuronide were about 
equal . This means that bilirubin monoglucuro-
nide-glucuronidating enzyme might also be active 
in the glucuronidation of p-ni t rophenol . 
Some clinical implications of these findings are 
discussed. 
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SUMMARY 
In aqueous media bilirubin monoglucuronide is subject to isomensation In 
this reaction two moles bilirubin monoglucuronide are converted into one mole biliru­
bin and one mole bilirubin diglucuronide Mainly the I l i a and I X a isomers of bilirubin 
were formed The tetrapjrrole moiety of bilirubin diglucuronide formed in this reac­
tion had mainly the X I H a and I X a structure Oxygen enhanced the reaction A free 
radical chain mechanism is the most hkelv process explaining our results 
INTRODUCTION 
The existence 01 bilirubin monoglucuronide as a chemical entity has been doubt­
ed for many ν ears B\ running aeproteimzed serum of patients with liver disease 
through a silicone treated kieselgulu column, Cole et all obtained three bands, rep­
resenting bilirubin and two more polai pigments The most polar one. Pigment I I , 
consisted of bilirubin and glucuronic acid in a 1 2 molar ratio and was shown to be 
bilirubin diglucuronide2 The other pigment, Pigment I, consisted of bilirubin and 
glucuronic acid m a i l molar ratio and was therefore thought to be bilirubin mono­
glucuronide' The finding, however that on repeated chromatography* this pigment 
dissociated into bilirubin and bilirubin diglucuronide led other authors to the conclu­
sion that Pigment I is an equimolar complex of bilirubin and bilirubin diglucuronide 
rather than bilirubin monoglucuronide3·4 Furthermore, by means of solvent partition 
at neutral pH, Nosslin5 recovered unconjugated bilirubin from Pigment I Because of 
the uncertain nature of Pigment I and because of the lack of unequivocal analytical 
methods, there has never been much attention paid to the differentiation of bilirubin 
monoglucuronide and bilirubin diglucuronide m the diagnosis of liver disease, in spite 
of some promising earlier s tudies ' - 8 
Recently', firm proof for the existence of bilirubin monoglucuronide was fur-
mshed · - 1 2 Bilirubin I X a is an asymmetrical molecule and its monoglucuronide deriv­
ative should therefore exist as two isomers, depending on which side of the moleci 'e 
the glucuronyl group is attached These two isomers could be separated by means of 
TLC, after substitution of the conjugating group by ΝΗ,ι, and their mass spectra were 
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analyzed™. In another study the structure of the azopigments, azodipyrrole and 
azodipyrrole-glucuronide, obtained by reaction of bilirubin monoglucuronide with the 
diazonium salt of O-ethyl anthranilate", was analyzed by means of mass spectro-
metry". These studies showed that both isomers of bilirubin monoglucuronide occur 
in human and rat bile. McDonagh and Assisi" have shown that bilirubin IXa may 
isomerise in aqueous media, producing two symmetrical isomers, bilirubin I l ia and 
bilirubin ΧΠΙα. We wish to report that also bilirubin monoglucuronide can undergo 
isomerisation, resulting in the production of bilirubin and bilirubin diglucuronide. 
MATERIAL AND METHODS 
Chemicals 
Organic solvents were analytical reagent grade. Bilirubin, ascorbic acid, sodium 
nitrite, methyl propyl ketone, и-butyl acetate, chloroform and ethyl acetate were 
purchased from Merck A.G., Germany. Uridine-s'-diphosphoglucuronic acid (ammo­
nium salt) was obtained from Sigma Chemical Co., St. Louis, Mo., U.S.A. Ammonium 
sulfamate was from Baker Chemicals N.V., The Netherlands. o-Ethylanthranilate was 
purchased from Eastman Organic Chemicals, Rochester, N.Y. and Triton X-roo from 
British Drug Houses Ltd., Poole, England. In thin-layer chromatography TLC-plates, 
Silica Gel 60, pre-coated, 20-го cm, layer thickness 0.25 mm from Merck A.G., Ger­
many, were used. 
Preparation of bilirubin monoglucuronide 
Bilirubin monoglucuronide was prepared enzymically. It is known that about 
90% of the bilirubin glucuronides formed during incubation of bilirubin and UDP-
glucuronate with a microsomal preparation from Wistar rat liver, consists of the mono­
glucuronide11. 
A microsomal preparation from Wistar rat liver was prepared as described pre­
viously". Before incubation, Triton X-ioo (0.25%, v/v) was added to this preparation. 
4.4 mg bilirubin was dissolved in 0.5 ml NaOH (0.05 M) and this solution was diluted 
with NaHIPOj-Na lHP04 bufier (0.1 M, pH 7.8). Incubation mixtures (48 ml) con­
tained: bilirubin (83 /iM), UDP-glucuronate (2.2 mM), MgCl, (3.3 mM), Tris-HCl 
buffer (0.1 M, pH 8.3) and the above described microsomal preparation. After in­
cubation during 40 min at 37o, the pH was adjusted to pH 3.2-3.4 by addition of 
HCl (2 M) and bilirubin and the formed glucuronides were extracted with 25 ml ethyl 
acetate*. After evaporation of the ethyl acetate phase in vacuo, the compounds were 
dissolved in 25 ml Tris-HCl buffer (0.1 M, pH 8.3). This solution was thoroughly 
shaken with 25 ml chloroform in order to extract the unconjugated bilirubin. After 
this, the pH of the aqueous phase was adjusted to pH 3.2-3.4 and the bihrubin glucu­
ronides were extracted with 25 ml ethyl acetate. Finally the ethyl acetate was evapor­
ated in vacuo and the conjugates were dissolved in Tris-HCl buffer (0.05 M, pH 8.3). 
Isomerisation of bilirubin monoglucuronide 
1 ml of the monoglucuronide preparation was added to 9 ml NaHjPOi-NajHPO« 
buffer (0.1 M, pH 6.5) containing ethanol (5%, v/v). At certain time intervals I ml 
samples were removed for analysis. In addition a sample was removed from the mono­
glucuronide preparation for immediate analysis. 
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In order to study the reaction as a function of pH, mixtures consisting of ο ι ml 
of the bilirubin monoglucuronide preparation, о 05 ml ethanol and 1 ml buffer, were 
incubated for 45 m m at room temperature The following buffers of varying pH were 
used Nab^PCVNajHPO, buffer (o 1 M), Tns-HCl buffer (o 1 M) and glycme-NaOH 
buffer (o 1 M) Immediately after incubation diazo reagent A (see next paragraph), 
was added 
Dunng aerobic incubations the mixtures were kept in open vessels which were 
gently shaken by hand In order to incubate the solutions anaerobically, М
г
 was passed 
through them The incubations were performed at 5 cm distance from an ordinary 
fluorescent lamp (Philips, TLD 15W/33) 
Détermination of bilirubin, bilirubin monoglucuronide and diglucuromde 
The tetrapynole molecule of bilirubin and glucuromdes is cleaved into two 
dipyrrole azopigments on reaction with the diazonium salt of 0 ethj 1 anthranilate11 
In aqueous media, at pH 2 8, only the conjugates of bilirubin react, but in organic 
media bilirubin also gives a positive dia70 reaction This allowed us to differentiate 
between bilirubin and its glucuromdes Thus, samples from the incubation mixtures 
were added respectively to Diazo reagent A, consisting of 4 ml glvcine-HCl buffer 
(0 1 M, pH 2 8) and 2 ml diazonium solution11, and Diazo-reagent B, consisting of 
4 ml acetone-ethanol (1 1, v/v) and 2 ml diazonium solution11 After incubation for 
30 mm at 25", 1 ml ascorbu acid (1 g/10 ml) was added to stop the diazo reaction The 
azopigments were extracted with methvl propyl ketone-и-butyl acetate (17 3, v/v) 
l· rom the solutions containing diazo B, the acetone-ethanol was evaporated and re­
placed by glycine buffer (o 1 M, pH 2 8) before extraction The extinction of the ex­
tracts was measured at 530 nm with a Beekman DB spectrophotometer The con 
ccntration of bilirubin and glucuromdes was calculated bv use of the previously de-
tei mined extinction coefficient (e^o 44 4XIO : , M - 1 cm - 1 ) for azopigments in the 
above mentioned extraction medium" 
In the diazo reaction one mole bilirubin diglucuromde gives rise to two moles 
azodipy rrole glucuromde One mole bilirubin monoglucuronide gives rise to one mole 
azodipyrrole and one mole azodipy rrole glue uronido in this reaction These two 
different azopigments can be separated b\ пгсяпь of thin-laver chromatographv 
Therefore samples from extract A were applied directly to pre-coatcd sihcagel plates 
These plates were de\ eloped twice first in chloroform and ubsequenth inchloroform-
methanol-water (65 25 3 v/v/v)11 The spots repiesonting azodipvrrole and azodi-
pyrrole-glucuronide, were cluted in methanol The extinction of the eluates was de­
termined spectrophotometncallv at 530 nm 1 rom these extinctions the mono /di­
glucuromde ratio could be calculated" 
Bilirubin isomers 
The tetrapyrrole structure of bilirubin and its glucuromdes u a s analwed ac­
cording to McDonagh and Assisi15 Bilirubin glucuromdes were hv droh zed In addition 
of 1 ml NaOH (1 M) to the incubation mixtures A pinch of ascorbic acid was added to 
prevent oxidation After 30 mm standing in the dark the solution was neutralized and 
the pigments were extracted with 4 ml chloroform Л sample of this extract was applied 
immediately to a sihcagel plate The plates were develoiied in chloroform-acetic acid 
(99 i , v/v) In order to determine the isomeric configuration of bilirubin, this com-
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pound was extracted from the incubation mixture with chloroform at pH 8.3. 
Chromatography of this extract was performed as described above. 
Commercial bilirubin is known to consist of bilirubin IXa with small amounts of 
bilirubin Illot and ΧΙΙΙα, and was therefore used as reference. The spots representing 
bilirubin Ilia, IXa and ΧΙΙΙα (in order of decreasing R/)15, wereeluted in chloroform-
methanol (1:1, v/v). The extinction of the eluates was measured at 450 nm. 
Abbreviations 
B, BDG and BMG represent bilirubin, bilirubin diglucuronide and bilirubin 
monoglucuronide, respectively. 
An aqueous solution, containing BMG in excess, was incubated at a short 
distance from an ordinary fluorescent lamp. In Table I it is seen that this resulted'in 
a gradual decrease of the BMG concentration whereas the В and BDG concentration 
concomitantly increased. In experiment 1 the BMG concentration in the first 8 min 
decreased by 7.4 μΜ, whereas the concentrations of В and BDG rose by 3.8 μΜ and 
3.7 μίΛ, respectively. In the second 8 min period the BMG concentration decreased 
by 6.5 μΜ, whereas the rise of В and BDG amounted to only 1.5 μΜ and 1.8 μίΛ. 
Experiment 3 in Table I shows a similar pattern. Incubation longer than 30 min 
resulted in a decreased recovery of all three compounds. In general it can be concluded 
from these experiments that about two moles BMG are converted into one mole В 
and one mole BDG. During prolonged incubation the part of the reaction leading to 
the formation of В and BDG becomes less complete until finally the rate of breakdown 
for В and BDG exceeds the rate of synthesis. 
In experiment 1 of Table I, the total decrease in the BMG concentration amount­
ed to 42%, which is about the same as the decrease in the first 15 min period in ex-
TABLE I 
THE 1SOMERISATION OF B M Ü AND THE FORMATION OF В AND B D G AT p H 6 5 
Mixtures containing BMG in excess, were incubated for different periods of time The amounts of 
B, BMG and BDG were determined before incubation and at different time intervals during in­
cubation, as described in MATERIALS AND METHODS. 
¡ncubatuyn Fu« 
/ime (mm) ¿ta20 В 
ι. Aerobically 
0 0 9 4 9 
8 0 9 5 0 
16 0.882 
2 Anaerobically 
0 0.765 
8 0.755 
16 0.775 
3. Aerobically 
0 0585 
15 0 570 
30 0.550 
4 i 0.505 
diazo A 
0837 
0753 
0651 
Э675 
0645 
0.625 
0.490 
0.410 
0340 
0.300 
azo-
dtpyrrole 
0 142 
0 107 
0081 
0.130 
0.144 
0115 
0094 
0.056 
0031 
0 024 
a -glu-
curomde 
0177 
0 170 
0 160 
0.12s 
0 127 
0.118 
0 170 
0 161 
0 14Я 
0 138 
Concentrations 
В 
S O 
8 8 
10 i 
4·· 
SO 
6 8 
A 3 
7 3 
9 5 
9.2 
BDG 
4 · 
7 .8 
9 6 
0 
'•5 
« 4 
6.3 
8 9 
1 0 0 
9-5 
(μΜ) 
BMG 
33 5 
2 6 1 
19 6 
З03 
2 7 5 
27 7 
¡5 7 
9 5 
5 3 
4 0 
Recovery 
По) 
— 
ιΟΟ 
93 
— 100 
ΙΟΙ 
— 
97 
94 
»7 
penment 3 When the incubation was performed anaerobically, the reaction proceeded 
significantly slower after 16 nun, the decrease in BMG amounted to only 9 % Thus 
oxygen apparently plays a role in this reaction More vigorous oxygenation of the 
solution, howevei, when for example a magnetic stirrer at high speed was used, re­
sulted in a decreased recoven' of all three compounds 
I t depends on the hydrogen ion concentration whether or not the reaction can 
take place When a BMG solution was incubated at different pH's, the maximal 
amount of BDG was formed at p H 6 5 as is seen in 1 ig 1 Before incubation 1 3 % of 
the mixture consisted of BDG This means that the BDG concentration in the mixtures 
with pH's below p H 5 2 or above pH 8 2 had actually decreased during the incuba­
tion, as can be derived from Fig 1 
Fig 1 Isomensation cf BMG, as function of the pH Incubation mixtures containing 6 7 /iM B, 
3 7 juM BDG (13 3%) and 17 3 /4M BMG were incubated for 45 mm and anal>zed as described in 
Material and Methods г Citratc-lSajHPO, buffer (o 1 M) · NaHjPOj-NajHPO, buffer (o 1 M) 
Δ. Tris-HCl buffer (o 1 M) 
Analysis of the isomeric configuration of the bilirubin derivatives revealed that 
before incubation the tetrapyrrole with the asymmetrical I X a configuration pre­
dominated over the symmetrical I l i a and Χ Ι Ι Ι α isomers (Table II) After incubation, 
the I X a isomer had proportionally decreased and the I l i a and Χ Ι Ι Ι α isomers had 
increased Furthermore, it can be seen in Table II that mainly the I l i a and I X a 
isomers of В were formed Without nsk of further isomensation, BMG and BDG 
cannot be separated, therefore the tetrapyrrole structures of BMG and BDG could 
not be studied separately From the data depicted in Table I I , however, it can easily 
be inferred that the formed BDG must consist mainly of Β Χ Ι Ι Ι α DG and В I X a DG 
From Table I I it can be deduced that all three BMG isomers, В I l l a MG, В I X a 
MG and Β Χ Ι Ι Ι α MG, have taken part in the reaction Before incubation the mixture 
contained 2 8 /iM В I l l a MG, 50 5 μΜ Β I X a MG and 13 ο μΜ Β Χ Ι Ι Ι α MG After 
incubation the total concentration of BMG amounted to 10 2 μΜ This means that 
the concentration of both Β I X a MG and Β Χ Ι Ι Ι α MG had decreased It can be 
calculated that the В I l l a MG concentration after incubation amounted to maximally 
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TABLE II 
ANALYSIS OF THE TETRAPYRROLE STRUCTURE OF B, B M G AND B D G , BEFORE AND AFTER INCUBA­
TION AT p H 6 5 
A mixture containing BMG in excess, was incubated aecobically for 45 mm. The amounts of B, 
BMG and BDG were determined before and after incubation The tetrapyrrole structure of B, 
BMG and BDG was determined after hydrolysis of the glucuromdeb In order to determine the 
isomeric configuration of B, this compound was extracted from the mixture with chloroform, as 
described in MATERIAL AND METHODS 
Time 
(тгп) 
о 
45 
Constituents 
B | B D G + B M G 
В 
B D G + B M G 
B + B D G ( B M G 
В 
B D G + B M G 
Tetrapyrrole isomer; 
Ilia IXa 
10 2 
53 3 
4 2 
2 8 4 
51 0 
0 6 
7 2 6 
4 6 7 
7 6 2 
4 2 0 
4 3 2 
4 0 5 
XIИ χ 
17 2 
0 
19 6 
29 6 
5 8 
5» 9 
Concentrations 
В BDG 
9 2 0 
39 4 2 1 9 
(μΜ) 
BMG 
6 6 3 
IO 2 
0.2 / Í M . Thus besides Β ΙΧα MG and Β Χ Ι Π α MG, also В I l l a MG must have taken 
part in the reaction. 
DISCUSSION 
Bilirubin and its conjugates react with the diazonium salt of o-ethyl anthranilate 
to form stable azopigments which can be quantitatively analyzed on TLC 1 1 . In aque­
ous media, at pH 2.8 (diazo A), only conjugated bilirubin reacts, with this reagent", 
whereas in an acetone-ethanol medium (diazo B) both conjugated and unconjugated 
bilirubin give a positive reaction1 6. 
In the present study a solution containing BMG in excess, was incubated and at 
different time intervals samples were drawn from it and submitted to botli diazo re­
actions. As a result of the incubation a significant and steady decrease of the products 
giving only a positive reaction with diazo A, was found. This is evidently the result 
of a reduction of the concentration of either BDG or BMG. Concomitant with this, an 
increased azodipyrrole-glucuronide/azodipyrrole ratio was found. Calculation of the 
absolute BMG and BDG concentrations revealed that BDG had increased and BMG 
decreased during incubation. 
Furthermore it was found that during incubation the products giving only a 
positive reaction with diazo B, had increased. This must be the result of a rise in the 
concentration of В as other possible reaction products, like pentdyopent pigments, 
do not react with diazo A or diazo B, or, as for example hydroxypyrromethenecarbinol, 
also give a positive reaction with diazo A " . 
In addition it was found that the tetrapyrrole moiety of the compounds did not 
keep the normal asymmetrical I X a configuration. This inevitably leads to the con­
clusion that our findings are the result of isomerisation of BMG. Under ideal circum­
stances two moles BMG were converted mto one mole В and one mole BDG, as a 
result of this process. Although the reverse reaction, the formation of BMG from В 
and BDG, was not studied in detail, there were some indications that this may occur 
below pH 5.2 or above pH 8.2. As the underlying mechanism for the observed reaction 
a free radical chain reaction is the most probable. The several possibilities of such a 
process are depicted in Fig. 2. The scheme in Fig. 2 has been set up for a solution only 
49 
I ig 2 Isomerisation of BMG b) means of a free radical mechanism The propagation of the re 
action 
G 
M — J — V iso\inyl isomer of В IXa MG 
G 
M — ν — ^ мп>1 isomer of В I X a MG 
Л — ν — ^ ^f—V—^г ^ І — ν — Μ represent Β I l l a В I X a and В Χ Ι Ι Ι α respectively I h e m o n o 
and diglucuronid». derivatives of these bilirubin isomers arc represented b> means of attachment 
of one or two glucuion>l groups ( *) to these structures 
G G 
\ — M — \ — ' M—"G represent free radicals with a dip>rrole or a dip>rrole methviene 
structure 
containing: Β Ι \ α MG The hcav\' printed pathv\a\s aro those wind, give rise to the 
compounds found in the analysis of Table II It іь apparent that the vin\l isomer of 
Β IXa MCr is more susceptible to isomensation than the iso\m\ 1 isomei The radicals 
depicted in the scheine can be either dip>rrole or dipjrrolt metlnlene fragments 
An important determinant for the reaction seems to Ы the In drogen ion concentration 
of the nudium O w g e n and light apparentlv have a ca taht ic eiiect on this process 
In particular owgen ma\ plav a role in the initiation of the reaction This, however, 
warrants further studj 
In older communications it has been reported that the so called Pigment I from 
the scrum of patients with liver disease on repeated chromatography dissociated into 
В and BDG 3 ' 4 This Chromatograph} has been performed at p H 6 (ref 3) at which 
pi I BMG easily isomenses into В and BDG Thus possibK Pigment I is BMG instead 
of a complex of В and BDG This evokes several questions Is BMG an impoitant 
50 
compound in the serum of patients with obstructive icterus ? Is BMG a toxic com­
pound as it may be the origin of radicals which may attach to tissue compounds as 
enzymes and DNA ? This may in particular play a role in the skin under the influence 
of light. Furthermore the question has to be reconsidered whether or not differentia­
tion of BMG and BDG by the determination of conjugated bilirubin holds promises for 
the diagnosis of liver disease. By development of methods for this, one has to reckon 
with the findings reported in the present communication. 
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Summary 
When bilirubin monoglucuronide is incubated with a preparation from tne 
105 000 X g-supernatant of deoxycholate-treated cat liver microsomes, bili-
rubin diglucuromde is formed This is an UDPíílucuronate-dependent reaction 
whereby bilirubin IXa monoglucuronide is stoichiometncally converted into 
bilirubin IXa diglucuromde 
The pH optimum for the conversion of bilirubin into ЬшплЬ:" monoglucu 
ronide lies between pH 8.0 and pH 8 8. For the conversion of mono- into 
diglucuromde two optima were found, one at about pH 6 5 and another at 
p H 8 . 1 
When the incubation was performed at pH 6.5 and the enzyme protein 
concentration was lowered, bilirubin monoglucuronide started to isomense. As 
a result of this isomensation bilirubin diglucuromde is also formed Diglucu­
romde formation according to this mechanism however, can be clearly differ­
entiated from the enzyme-catalyzed diglucuromde formation. 
By the formation of bilirubin monoglucuronide, one monoglucuronide 
isomer is preferentially synthesized. 
The alkaline-labile bilirubin conjugates in the bile of cats and rats have 
mainly the IXa isomeric structure This suggests that in these animals bilirubin 
diglucuromde is formed enzymically as the bilirubin moiety of diglucuromde, 
formed by means of the isomensation reaction, has predominantly the ΧΙΙΙα 
structure. 
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Introduction 
Before excretion in the bile, bilirubin is conjugated with glucuronic acid, 
glucose or xylose [1 ,2] . Furthermore bilirubin may be conjugated with dis-
acchandes [ 3 ] . Bilirubin diglucuromde however, is the most important con-
jugate in normal mammalian bile [1 ,2] . 
The question as to how this diglucuromde is formed in the liver has not 
yet been fully answered It has been reported that both bilirubin monoglucu-
ronide and diglucuromde are formed when bilirubin and UDPglucuronate are 
incubated with homogenates from rat [4,5] or cat [6] livers. The monoglucu-
romde/diglucuronide ratio is influenced by several factors. For rats, strain dif-
ferences seem to play a role Fevery et al. [4] reported the tormation of 
predominantly the monoglucuronide with homogenates from Wistar rat livers. 
In contrast Halac et al. [5] found that with preparations from the rough 
microsomal fraction from the livers of Fisher strain rats, the diglucuromde was 
formed in excess But after storage of this preparation for 72 h, almost only 
bilirubin monoglucuronide was formed. In our laboratory it was observed that 
incubation with preparations from cat liver yielded about equal amounts of 
mono- and diglucuromde [ 6 ] . Pretreatment of these preparations with Tween 
80 caused a shift in their ratio towards the latter compound. These results 
suggest that the conversion of bilirubin into its diglucuromde occurs in two 
distinct steps, with the monoglucuronide as an intermediate 
In the first step glucuronic acid is attached to a carboxyl group of biliru-
bin. This must be an enzyme-catalyzed reaction as it is well known that the 
glucuronidation of unconjugated bilirubin requires the presence of UDPglucu-
ronate and homogenates or microsomal preparations from liver, kidney or in-
testinal tissue [7] Only for N-glucuromdes it is known that they may be 
synthesized in a non-enzymic way [ 7 ] . Recently it was found that bilirubin 
diglucuromde may also be formed non-enzymically, by means of isomensation 
of bilirubin monoglucuronide [8] In this reaction 2 moles monoglucuronide 
are converted into 1 mole of unconjugated bilirubin and 1 mole of diglucu-
romde. This only occurred between pH 5 2 and pH 8 2, with an optimum at 
pH 6.5. Whether this mechanism plays a role by diglucuromde formation in the 
liver or does only occur, in vitro, in protein-free media, has not been studied 
yet Possibly, diglucuromde formation m the liver occurs by means of an 
enzyme-catalyzed transfer of glucuronic acid from UDPglucuronate to the free 
carboxyl of bilirubin monoglucuronide The present study was undertaken to 
elucidate this. 
Materials and Methods 
Animals 
Cats were 12 - 1 8 months and Wistar rats 3 months old. Only male animals 
were used. Before killing the animals were fasted for 12 h. 
Chemicals 
Bilirubin, L(+)ascorbic acid, sodium nitrite, EDTA (disodmm salt), 
sucrose, tns(hydroxymethyl)aminomethane, mono- and dibasic sodium phos-
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phate, glycine, citric acid, MgCl2 and the organic solvents methyl propyl 
ketone, n-buty' acetate and ethyl acetate were purchased f'om Merck A G , 
Darmstadt, Germany. Undine 5'-diphosphoglucuronic acid (ammonium salt) 
and 7-deoxycholic acid (sodium salt) were obtained from Sigma Chemical Co., 
St. Louis, Mo., U.S.A. Ammonium sulfamate was from J.T. Baker Chemicals 
N.V., Deventer, The Netherlands Glucaro-l,4-lactone was from Calbiochem, 
San Diego, Calif , U.S.A. o-Ethylanthramlate was purchased from Eastman 
Organic Chemicals, Rochester, N.Y., U.S.A. and Triton X-100 from British 
Drug Houses Ltd, Poole, England Sephadex G-25, coarse, was from Pharmacia 
Fine Chemicals А В., Uppsala, Sweden. 
In thin-layer chromatography plates (glass), Silica Gel 60, precoated, 20 
cm X 20 cm, layer thickness 0.25 mm from Merck A.G., Darmstadt, Germany, 
were used. 
Tris buffer was prepared by adding 0.2 HCl to a 0.2 M Tris solution until 
the desired pH and this solution was diluted with distilled water until a final 
Tris concentration of 0 05 M or 0 1 M. Glycine—NaOH and glycine—HCl buffer 
was made by the addition of 0.2 M NaOH or 0.2 M HCl, respectively, to a 0 2 
M glycine solution. After the desired pH was reached, the solutions were 
diluted to a glycine concentration of 0.1 M, phosphate buffer was made by 
mixing solutions of 0.1 M monobasic phosphate and 0.1 M dibasic phosphate 
until the desired pH. Citrate—phosphate buffer was made by mixing solutions 
of 0.1 M citric acid and 0.2 M dibasic phosphate until the desired pH. 
Equipment 
Cat liver was homogenized with an Ultra-Turrax apparatus from Janke 
und Kunkel К G., Staufen ι Br., Germany, and rat liver with a Teflon-glass 
Potter— Elvehjem homogemzer from Tn-R Instruments Rockville Centre, N.Y., 
U.S.A. The operation speed of these apparatuses was 8000 and 5000 rev./mm, 
respectively 
Low speed centnfugation was done with a Heraeus—Chnst Type U J3 centn-
fuge For centnfugation at 9000 X g an Ι.E С. B-20 centnfuge was used. A 
Chnst Omega LI ultracentrifuge was used for centnfugations at 105 000 X g 
Spectrophotometrical determinations were done with a Beckmannn DB 
spectrophotometer. For the scanning of chromatograms a Zeiss PMQ II spectro­
photometer, equipped with a scanning apparatus, was used. pH measurements 
were done with a Radiometer Model TTT2 pH meter, provided with a combina­
tion electrode. 
Microsomal preparations 
20% (w/v) homogenates were prepared from cat or rat liver in Tris buffer 
(0.05 M, pH 7 8), containing sucrose (0.25 M) and EDTA (sodium salt) 
(0.01 M). The homogenates were centnfuged at 9000 X g, for 20 mm at 2 0 C. 
These supernatants were centnfuged at 105 000 X g for 1 h at 2 0 C. The micro­
somal fraction, thus obtained, was suspended in the homogemzation medium. 
1 ml of suspension contained microsomes denved from 1 g of liver. 
Solubilized fractions from cat lioer microsomal preparations 
To the microsomal suspension from cat liver, solid deoxycholate (0.3%, 
54 
w/v) was added. After stirring for 4 h -at 4° С with a magnetic stirrer, the 
suspensions were centnfuged at 105 000 X g for 1 h. The clear phase of the 
supernatant was passe4 over a column (16 mm X 1000 mm) containing Sepha-
dex G-25, coarse. As an elution fluid Tris buffer (0.05 M, pH 7.8), containing 
KCl (0.14 M) and EDTA (0.01 M), was employed This procedure is a modifica­
tion of the method described by Halac and Reff [ 9 ] . After it was found that a 
more active preparation was obtained with use of a larger Sephadex column 
(30 mm X 1000 mm), the above mentioned column was replaced by the latter. 
Glucuromdation of bilirubin 
Bilirubin (4.4 mg) was dissolved in 0.5 ml 0.05 M NaOH and this solution 
was diluted with phosphate buffer pH 7.8 (1 : 30, v/v). Incubation mixtures 
consisted of 0.2 ml of the bilirubin solution (final concn 83 μΜ), 0.2 ml solu-
bilized enzyme preparation from cat liver (final protein concn 1.5 mg/ml) and 
0.8 ml Tns buffer (0.1 M, pH 8.3) containing UDPglucuronate, MgClz and 
glucuro-l,4-lactone (5 mM, 3.3 mM and 1 mM, respectively; all final concns). 
When the reaction was studied as function of pH, the pH of the Tris buffer was 
varied or the Tns buffer was replaced by phosphate or glycine — NaOH buffer of 
varying pH. After incubation for 30 mm at 37°С in a shaking water bath, the 
mixtures were submitted to the diazo reaction described by Van Roy and 
Heirwegh [ 1 0 ] . After reaction with the diazomum salt of o-ethylanthramlate, 
in an aqueous medium at pH 2.8, the azo pigments were extracted with methyl-
propyl ketone—η butyl acetate (17 · 3, v/v) and the colour of this extract was 
determined spectrophotometrically at 530 nm. Conjugated bilirubin was calcu­
lated assuming 6530 44.4 X l O ^ M - ^ c m - 1 (ref. 10) 
In the diazo reaction the tetrapyrrole molecule of conjugated bilirubin is 
cleaved into dipyrrole azo pigments. One mole bilirubin diglucuronide gives rise 
to two moles azodipyrrole glucuromde and one mole bilirubin monoglucu­
ronide to one mole azodipyrrole and one mole azodipyrrole glucuromde The 
two different azo pigments can be separated by means of thin-layer chromato­
graphy and from their ratio the amounts of mono- and diglucuronide can be 
calculated (formula for calculation is given in refs 11 and 6) Thus, samples of 
the azo pigment extract were applied directly on silica gel plates and the 
chromatograms were developed first in chloroform and subsequently in chloro­
form—methanol—water (65 : 25 · 3, v/v/v) [ 4 ] . The two clearly defined spots, 
representing the azo pigments, were eluted in methanol and their extinction 
was measured at 530 nm. 
Preparation of bilirubin monoglucuronide 
Bilirubin monoglucuronide was prepared biosynthetically. 0 02 ml of 
Triton X-100 was dissolved in 8 ml of rat liver microsomal preparation. The 
incubation mixtures consisted of this solution and 8 ml of bilirubin solution 
(prepared as described in the previous paragraph) together with 32 ml of Tris 
buffer (0.1 M, pH 8.3) containing UDPglucuronate and MgClz (2.2 mM and 
3 3 mM, respectively, final concns). After incubation for 40 mm at 37°C, the 
pH was adjusted to pH 3.2 with 2 M HCl. Bilirubin and the formed glucu-
ronides were extracted with 25 ml ethyl acetate [ 1 1 ] . After evaporation of the 
ethyl acetate in vacuo,4 the residue was dissolved in 25 ml Tris buffer (0.1 M, 
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pH 8.3). From this solution, unconjugated bilirubin was partly extracted with 
chloroform. The pH of the aqueous phase was adjusted tc pH 3.2 and the 
bilirubin glucuromdes were extracted with 25 ml ethyl acetate. Finally the 
ethyl acetate phase was evaporated in vacuo and the residue was dissolved in 
Tns buffer (0.05 M, pH 8 3).After its preparation, the monoglucuronide solu­
tion was used without delay. 
Glucuromdation of bilirubin monoglucuronide 
The incubation mixture consisted of 0.2 ml of monoglucuronide solution 
(concn specified in tables and figures), 0.2 ml of solubihzed enzyme prepara­
tion from cat liver and 0 8 ml of phosphate buffer (0.1 M, pH 6.5) containing 
UDPglucuronate, MgCl2 and glucaro-1,4-lactone (3 mM, 3.3 mM and 1 mM, 
respectively, final concns). In a part of the study the pH of the phosphate 
buffer was varied or this buffer was replaced by citrate—phosphate buffer, Tris 
buffer or a glycine — NaOH buffer of varying pH. The mixtures were made in 
duplicate. One was submitted to the diazo reaction after incubation for 30 mm 
at 37°C, and in the other one the diazo reaction was immediately started, 
without prior incubation. In this way the mono- and diglucuronide concentra­
tions, after and before incubation, could be determined. 
In experiments where besides the mono- and diglucuronide concentration 
also the concentration of unconjugated bilirubin was determined, the volume 
of the above described incubation mixture was doubled. An aliquot of 1.2 ml, 
taken from the incubated anf from the non-incubated tube, was processed as 
described above. To an equal aliquot 4 ml of acetone—ethanol ( 1 : 1 , v/v) and 2 
ml of diazo reagent was added. The diazo reaction was allowed to proceed for 
30 min at 25°С and was stopped by adding 0.5 ml of ascorbic acid (1 g/10 ml). 
Acetone · ethanol was evaporated in vacuo, and 4 ml of glycine — HCl buffer 
(0.1 M, pH 2.8) was added. The azo pigments were extracted with methyl-
propyl propyl ketone—η-butyl acetate (17 . 3, v/v), the extinction was mea­
sured at 530 nM and the amounts of bilirubin plus glucuromdes were cal­
culated. The glucuronide concentration was subtracted from this value to yield 
the amount of unconjugated bilirubin. 
Bilirubin isomers 
Bilirubin glucuromdes were hydrolyzed by the addition of 1 ml IM NaOH 
(final pH 12.3) to the incubation mixture. A pmch of ascorbic acid was added 
to prevent oxidation. After 30 mm the solution was neutralized (pH 7.4) and 
the pigments were extracted with 4 ml of chloroform. A sample of this extract 
was immediately applied to a silica gel plate The plates were dryed with N2 
and developed without delay in chloroform—acetic acid (99 . 1 , v/v) [ 1 2 ] . The 
spots representing the bilirubin isomers Il ia, IXa and ΧΙΙΙα [ 1 2 ] , were eluted 
in chloroform—methanol (1 · 1, v/v). As reference standard, a chloroform 
extract from the previously described bilirubin solution was used. The chro-
matogram of this extract revealed besides an abundant amount of bilirubin IXa 
also two faint spots representing bilirubin Ilia and ΧΙΙΙα. The extinctions were 
measured at 450 nm. 
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Bile 
Bile from rats was collected during 10 h after cannulation of their bile 
ducts. Cat bile was obtained by aspiration from the gall bladder, after killing 
the animal. Bile samples were submitted to the diazo reaction at pH 2.8 and 
chromatograms were developed according to Fevery et al. [ 4 ] . 
For determination of the bilirubin isomers in bile, the glucuronides were 
hydrolyzed and the isomeric composition was determined by means of thin-
layer chromatography, exactly as described in the previous paragraph. The 
chromatograms were scanned at 450 nm. 
Azodipyrrole and azodipyrrole glucuronide vinyl—isovinyl isomerism 
The vinyl and isovinyl isomer of azodipyrrole and azodipyrrole glucu­
ronide were determined as described by Jansen and Stoll [ 1 3 ] . 
Protein determination 
This was done as described by Lowry et al. [14] . 
Results 
Bilirubin and bilirubin monoglucuronide were incubated at different pH 
values with UDPglucuronate and the solubilized fraction from cat liver micro­
somes. In Fig. 1 it is seen that the pH optimum for the glucuronidation of 
unconjugated bilirubin lies between pH 8.0 and pH 8.8. For the conversion of 
Fig 1. The conversion of bilirubin and bilirubin monoglueuronide as function of pH. Upper panel: 
blbrubm (83 μΜ) was incubated with UDPKlucuronate (5 mM) and a sohibibzed preparation from cat liver 
for 30 mm at 37' C. ( · ) Phosphate buffer (0.1 M); (X) Tris buffer (0.1 Μ). <л> Glycine—NaOH buffer 
(0.1 M) Lower panel: Bilirubin monoelucurontde was incubated with UDPglucuronate (Э mM) and a 
solubilized preparation from cat liver for 30 min at 37°C. (X) Citrate—phosphate buffer (0.1 M), substrate 
concn 22 μΜ monoglucuronide; (o) phosphate buffer (0.1 M), 24 μΜ monoglucuronide: ( · ) phosphate 
buffer (0.1 Μ). 16μΜ monoglucuronide: (·*>) glycine-NaOH buffer (0.1 M). 17 μΜ monoglucuronide. The 
onlinate represents the amount of substrate converted in 30 min. 
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TABLF I 
Incubation of bilirubin monoglucuronide at pH 8 1 and pH 6 5 in the presence ard in the absence of an 
enzyme preparation from cat liver The incubations were performed for 0 and 30 m m at 37°С The mix­
tures 1 and 4 were protein-free whereas the mixtures 2, 3, 5, 6, 7 and 8 contained a solubilized enzyme 
preparation from cat liver UDPslucuronate (UDPGA) (3 mM) was added to Mixtures 3 and 6. UDP (9 mM) 
to Mixtures 7 and β В, BMG and BDG are expressed as nmoles/ml incubation medium, and represent 
bilirubin monoglucuronide and diglucuromde, respectively 
Conditions 
1 ρ Η β Ι - Ь - U D P G A 
2 pH8 1 + E - UDPGA 
3 pH8 1 + E + UDPGA 
4 PH6 5 - E - U D P G A 
5 pH6 5 + b - U D P G A 
6 pH6 5 + l · + U D P G A 
7 pHB 1 + E + UDP 
β pH6 5 + E + UDP 
Time 
0 
3 0 
0 
3 0 
0 
3 0 
0 
3 0 
0 
3 0 
0 
3 0 
0 
3 0 
0 
3 0 
в 
1 2 4 
8 6 
12 4 
11 7 
7 5 
8 9 
5 0 
8 6 
1 3 9 
17 0 
7 5 
9 0 
12 4 
9 8 
1 3 9 
13 9 
BMG 
19 6 
2Ь4 
19 6 
2 0 5 
18 2 
2 0 
17 0 
7 6 
14 9 
1 8 9 
1 8 2 
2 0 
19 6 
17 5 
14 9 
12 5 
BDG 
2 2 
0 
2 2 
1 3 
3 4 
19 3 
4 4 
9 6 
1 0 
2 1 
3 4 
17 1 
2 2 
2 0 
1 0 
2 7 
Recovery (%) 
_ 
100 
— 
9 8 
— 
104 
_ 
96 
_ 
127 
— 
97 
_ 
86 
_ 
9 8 
mono- into diglucuronide two optima were found One at pH 8.1 and another 
one at pH 6 5 
Incubation of bilirubin monoglucuronide at pH 6 5, in the absence of 
enzyme protein, results in its isomensation (Table I, Reaction 4). At pH 8.1, a 
reverse reaction takes place under these circumstances 
(1 bilirubin + 1 diglucuronide ->• 2 monoglucuronide, Reaction 1), 
confirming our earlier findings [8] Both these reactions are inhibited in the 
presence of enzyme protein (Reactions 2 and 5) After addition of enzyme 
protein, diglucuronide only occurs in the presence of UDPglucuronate. This 
was found at both pH 6 5 and pH 8.1 (Reactions 3 and 6). 
Table II shows that by diglucuronide formation by means of isomensation 
of bilirubin monoglucuronide, a rearrangement of the tetrapyrrole moiety oc­
curs. This, obviously, did not occur by the formation of diglucuronide in the 
presence of UDPglucuronate and enzyme protein. The data of Tables I and II 
show that this latter reaction occurs according to the equation 
1 bilirubin IXa monoglucuronide -* 1 bilirubin IXa diglucuronide 
It has been reported that the glucuromdation of p-mtrophenol can also occur in 
the reverse direction [ 1 5 ] . In order to study whether this also holds true for 
the glucuromdation of bilirubin, monoglucuronide was incubated with UDP 
and a solubilized preparation from cat liver This, however, did not result in the 
formation of bilirubin, as is shown in Table I (7 and 8). 
When unconjugated bilirubin is used as substrate and the incubation is 
performed at pH 8.1, both mono- and diglucuronide are formed. This is obvi­
ously the consequence of the finding that at pH 8.1 both glucuromdation steps 
can take place In Fig. 2 the amounts of mono- and diglucuronide, present at 
the end of the incubation, are depicted. The sum of these amounts is equal to 
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TARLh II 
The isomeric configuration of the büin bin moiety by the spontaneous and the enzyme-catalyzed forma-
tion of bilirubin diglucuronide Mixtu ^s containing bilirubin monoglucuronide were incubated and the 
diglururomdc concentration before ai>d after incubation was determined The percentage diglucuronide 
[diglururomde/(bilirubin, mono'+diglucuronidc) X 1 0 0 ] is represented in the table. Mixtures 1 and 2 were 
incubated in the presence of a solubüizcd preparation from cat liver and UDPglucuronate (3 mM> for 0 and 
30 min at 37 0 C Mixture 3 was protein-tiee and was incubated for 0 and 45 m m at room temperature For 
analysis of the tetrapyrrole structure of bilirubin and its glucuromdcs, the mixture was treated with NaOH 
and analyzed as described in Material and Methods. 
Mixtures Conditions 
1 ρΗβ.Ι + E + UDPGA 
2 pH6 5 + E + UDPGA 
3 p H 6 . 5 - L - UDPGA 
Time 
0 
30 
0 
30 
0 
4 5 
BDG(%) 
12 
6 3 
12 
61 
0 
31 
Tetrapyrrole isomers (%) 
I l ia 
13 
11 
13 
13 
1 0 
28 
IXa 
6 3 
69 
63 
6 2 
73 
4 2 
XHIa 
24 
2 0 
2 4 
2 5 
17 
3 0 
the total amount of bilirubin converted into monoglucuronide during the reac­
tion. In Fig. 2 it is seen that coupling of the first glucuronic acid molecule to 
bilirubin is a linear function of time. After a certain lag period also the conver­
sion of mono- into diglucuronide is a linear function of time and proceeds at 
the same rate as the first step. 
With bilirubin monoglucuronide as substrate some characteristics of the 
second glucuromdation step were studied. In Fig. 3 it is seen that the conver­
sion of mono- into diglucuronide is a linear function of time at both pH 6.5 
and p H 8 . 1 . In Fig. 4a it is shown that the non-UDPglucuronate-dependent 
conversion of mono- into diglucuronide by means of the isomensation reaction 
η moles/mí protein— 
1 0
Ί 
10 20 30 
minutes 
Fig 2 The formation of bilirubin mono and diglucuronide during incubation of bilirubin, as function of 
time Bilirubin ( 8 3 μΜ) was incubated with UDPglucuronate (5 τηΜ) and a solubihzed preparation from 
cat liver, for varying periods of time at 37 С After incubation the mixtures were submitted to the diazo 
reaction as described in Materials and Methods The azo pigments were extracted with methyl-
prop у 1 ketone—n-bulyl acetate (17/3, v/v) The extinction of these extracts was determined at 5 3 0 nm. 
This allowed the calculation of the total amount of bilirubin conjugated Ahquots of the extracts were 
applied to silica gel plates Aficr development of the chromatograms the spots, representing azodipyrrole 
and azodipyrrole—glucuronide. were elutcd and the extinction of the eluates was determined at 5 3 0 nm. 
On the basis of these data, the amounts of bilirubin mono- and diglucuronide could be calculated. X, total 
amount of bilirubin conjugated, · , bilirubin monoglucuronide, , diglucuronide Note, in the experiments, 
depicted m Figs 1 and 2, the smaller type Sephadcx column (16 mm X 1 0 0 0 mm) was used, by the 
preparation of the enzyme preparation In all other experiments, deoxycholate was washed from the 
enzyme preparation with a largar Sephadex column ( 3 0 mm X 1 0 0 0 mm) 
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Fig. 3. The converaion of büifubUi monoElucuronide into diclucuronide as function of tune, χ, bilirubin 
monoghicuromde (19 μΜ) was incubated with 3 mM UDPglucuronate and a solubllized enzyme prepara­
tion from cat liver for varying periods of time at pH β.Ι. о, 13 μΜ monoglucuronide was incubated at 
pH 6 5 under the same condit ions The ordinate represents the amount of diglucuromde. produced at the 
different time Intervals, in nmoles/mg protein The incubation time is depicted on the abscissa 
becomes more important at lower enzyme protein concentrations. This causes 
the curve, representing the formation of diglucuronide at pH 6.5 as function of 
tha enzyme protein concentration not to go through zero. The calculated 
curve, however, representing the UDPglucuronate-dependent reaction, did not 
show this deviation and resembled the curve obtained at pH 8.1 (Fig. 4b). 
The UDPglucuronate dependence of the enzyme-catalyzed bilirubin diglu­
curonide formation at pH 8.1 and 6.5 is shown in Fig. 5 by means of a Line-
050 150 
b) pH β I 
/ 
/ 
/ / 
Û2S 0*0 075 
mg proti m/trJ 
Fig. 4. The formation of bilirubin diglucuromde at a function of the protein concentration. In Fig. 4a 
bilirubin monoglucuronide (24 μΜ) was incubated at pH 6.5. with ( · ) and without (O) UDPglucuronate 
( 3 mM) and a solubilized preparation from cat liver The concentration of the enzyme preparation was 
vaned. Line (X) was obtained through subtraction of the lower from the upper Une. In Fig. 4b monoglu­
curonide ( 1 9 μΜ) was incubated at pH β 1 under the tame conditions. The abscissa represents the final 
protein concentration and o n the ordinate the amount of diglucuronide, produced In 15 m in/ml incuba­
tion medium, is depicted. 
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Flg 5 The glucuronidalion of bilirubin monoelucuronide as a function of UDPelucuronate Lineweaver— 
Butk plot UDPelucuronate. in varying concentrations and solubili/ed en/уте preparation from cat liver 
were incubated with 16 μΜ bilirubin monoglucuronide at pH 8 1 ( · ) or with 17 μΜ bilirubin monoglucu­
ronide at pH 6 5 ( ) for 15 mm at 3 7 0 C The reciprocal values for the initial velocities, obtained at 
different UDPglucuronate concentrations are plotted on the ordinate 
weaver-Burk plot. From these plots the following kinetic constants can be 
derived: Ä U D P G A 0.44 mM, V 12 0 nmoles/15 mm per mg protein at pH 8.1 
by a fixed bilirubin monoglucuronide concentration of 16 μΜ, and / С П О Р О Л 
0.36 mM, V 9 4 nmoles/15 min per mg protein at pH 6 5 by a fixed bilirubin 
monoglucuronide concentration of 17 juM. 
Site of attachment of the glucuronyl group 
Bilirubin IXa, the natural heme breakdown product, is an asymmetrical 
molecule. Therefore, two bilirubin IXa monoglucuronide isomers could exist, 
depending on the site of attachment of the glucuionyl group (either Rj or R2 
in Fig. 6). Proof for the existence of these two isomers has been given by 
Jansen and Billing [16] . The two isomers can be distinguished by means of 
analysis of their azo pigments [13] . When, in Fig. 6, Ri = glucuronic acid, 
equimolar amounts of vinyl azodipyrrole glucuromde and isovinyl azodipyrrole 
are derived from the compound in the diazo reaction, when R2 = glucuronic 
acid, equimolar amounts of isovinyl azodipyrrole-glucuronide and vinyl azo­
dipyrrole are derived from it From Table III it can be derived that the glucu­
ronyl group is preferentially attached to R ] , when unconjugated bilirubin is 
incubated with UDPglucuronate and a Triton X-lOO-treatcd rat hver micro­
somal preparation. If by the glucuromdation of bilirubin monoglucuronide the 
same preference for glucuromdation of R! should exist, the azodipyrrole glucu-
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Fig. β. The formation of izo pigments in the dUzo reaction. 
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TABLE III 
The site of attachment of the glucuronyl group by the conversion of bilirubin into monoglucuronide and 
by the conversion of mono- into diglucuronide. Bilirubin (83 μΜ) was incubated with UDPglucuronate 
(3 mM) and a Tnton X-100 {0.25%, v/v>-treated microsomal preparation from rat liver for 1 0 and 2 0 m m 
at 37°C. Bilirubin monoglucuronide (19.9 and 17.9 μΜ) was incubated with UDPglucuronate (3 mM) and 
a solubilizcd preparation from cat liver for 0 and 14 mm at 3 7 0 C . After incubation, the diazo reaction 
was performed and the azo pigments were separated by thin-layer chromatography. Subsequently the azo-
dip y π oie-glu euro m de pigment was treated with methanol and H2SO4 and the vinyl/isovinyl ratio was de­
termined as described by Jansen and S toll [ 1 3 ] . B, BMG and BDG represent bilirubin, mono- and diglucu­
ronide. BMG and BDG arc expressed as nmoles/ml incubation medium. 
Substrate Enzyme preparation pH 
В 
BMG 
BMG 
Time 
10 
20 
0 
14 
0 
14 
BMG 
9.6 
18.5 
19.9 
14.2 
17.9 
10.7 
BDG 
0 
0 
0.6 
9.В 
0.5 
7.7 
Azodipyrrole—glucuromde 
vinyl/isovinyl ratio 
3.8 
3.3 
3.1 
1.8 
3 7 
2.1 
ronide vinyl/isovinyl ratio should increase as a result of the second step reac­
tion. In Table III it is seen that this was not the case. 
Formation of bilirubin diglucuronide in vivo 
In our previous communication it has been reported that the bilirubin 
moiety of diglucuronide, formed by means of isomensation of monoglucu­
ronide, has to a significant extent the isomeric structure of bilirubin ΧΙΙΙα [ 8 ] . 
In order to study which mechanism accounts for the formation of diglucu­
ronide in vivo, the isomeric structure of the alkaline-labile bilirubin conjugates 
in cat and rat bile was analyzed. Azo pigment analysis revealed that 70 -100% 
of the bilirubin derivatives in cat bile and 38 - 50% of the bilirubin derivatives 
in rat bile were diglucuronides. From Fig. 7 it can be derived that the alkaline-
labile bilirubin conjugates in bile of cats and rats have predominantly the IXÛ 
isomeric structure, suggesting that both in cats and rats, diglucuronide is 
formed enzymically. 
Cm 
Fig. 7, Bilirubin isomers in bile from Wistar rat and cat. After hydrolysis of the bilirubin glucuromdes the 
bilirubin isomers were analyzed according to the method of McDonagh and Assisi [ 1 2 ] . The picture 
represents the scan of the silica gel plate The remittance at 4 5 0 nm is depicted on the ordinate and the 
migration distance (from left to right) o n the abscissa. 
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Discussion 
In vitro, bilirubin diglucuronide can be formed in two ways In the pre-
sence of a solubilized preparation from cat liver microsomes, however, mono-
glucuronide was only converted into diglucuromde after addition of UDPglucu-
ronate. Diglucuromde formation by means of isomensation of monoglucu-
ronide was inhibited in the presence of a certain amount of enzyme protein. 
The stoichiometry of the isomensation and the UDPglucuronate-dependent 
reaction were considerably different, as m the latter instance 1 mole of mono-
glucuronide was converted into 1 mole of diglucuromde It was furthermore 
found that the tetrapyrrole structure of these compounds stayed the same in 
this process, in contrast to the changes observed by the isomensation reaction. 
These results evidently show that, besides diglucuromde formation by means of 
isomensation, diglucuromde may be formed by an enzyme-catalyzed transfer 
of the glucuronyl group from UDPglucuronate to the monoglucuronide. Analy-
sis of cat and rat bile suggests that diglucuromde formation by means of the 
isomensation reaction is not an important mechanism in the liver of these 
animals. 
The present study substantiates our previous findings that the formation 
of bilirubin diglucuromde occurs in two distinct steps [ 6 ] . Indications were 
found that these steps are catalyzed at different active sites. At pH 8.1 uncon-
jugated bilirubin was converted into bilirubin diglucuromde and it was shown 
that at this pH both glucuromdation steps can be mediated. Another pH op-
timum for the conversion of mono- into diglucuromde was found at pH 6.5, 
and at this pH unconjugated bilirubin was hardly accepted as substrate. These 
findings suggest the existence of a bilirubin glucuronyltransferase with an 
optimum at pH 8 1 and a bilirubin monoglucuronide glucuronyltransferase 
with an optimum at pH 6 5. 
The question whether the conversion of mono- into diglucuromde at 
pH 8.1 takes place at the same active site as the conversion of bilirubin into its 
monoglucuronide, is difficult to answer It was found that p-nitrophenol in-
hibits the conversion of mono- into diglucuromde at pH 8 1 in a competitive 
way whereas the first glucuromdation step was not influenced by this aglycone 
[6] This is an indication that besides a bilirubin monoglucuronide glucuronyl-
transferase with an optimum at pH 6.5 there may be another active site for this 
reaction with an optimum at pH 8.1, different from the above mentioned 
bilirubin glucuronyltransferase. This assumption is substantiated by our finding 
that with a microsomal preparation from Wistar rat liver or with the solubilized 
fraction from it, only the first bilirubin glucuromdation step is mediated at pH 
8 1 (unpublished results). This suggests that the site for the mediation of the 
second step at high pH, is deficient in Wistar rat liver. Use was made of this fact 
with the preparation of bilirubin monoglucuronide in the present study. Halac 
et ill. [ 5 ] found that upon incubation of unconjugated bilirubin with a rat liver 
microsomal preparation at pH 8.0, the diglucuromde was formed in excess over 
the monoglucuronide. This suggests that their Fischer strain rats differ m this 
respect from Wistar rats (also used in ref. 4) and from Sprague—Dawley rats 
[17,18] . 
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SUMMARY 
UDPglucuronyltransferase was solubilized by treating Wistar 
rat liver microsomes with deoxycholate. Chromatography of 
this preparation on Bio-Gel Ρ 30 resulted in extraction of 
92% of phospholipids and complete loss of enzyme activity. 
UDPglucuronyltransferase was reactivated by dialysing this 
delipidated preparation in the presence of lecithin, a mix­
ture of liver microsomal lipids or liver microsomal membra­
nes from homozygous UDPglucuronyltransferase deficient Gunn 
rats. Phosphatidylserine or phosphatidylethanolamine were 
without effect. 
Virtually complete enzyme reactivation was obtained with re­
gard to glucuronidation and glucosidation of bilirubin; how­
ever, the inactivation of UDPglucuronyltransferase with p-
nitrophenol as substrate was irreversible. 
These findings demonstrate that UDPglucuronyltransferase 
with bilirubin as substrate is a lipid-requiring enzyme. 
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INTRODUCTION 
UDPglucuronyltransferase (UDPglucuronate glucuronyltransfe-
rase, EC 2.4.1.171 catalyzes the glucuronyl conjugation of 
several small molecular compounds. The enzyme Is important 
in conjugation of hormones, products of endogenous metabo­
lism, drugs and toxic compounds . Many investigators have 
tried to determine whether glucuronidation of these com­
pounds is mediated by a single enzyme or whether different 
UDPglucuronyltransferases exist ' ' ' ' . Attemps to sepa­
rate and purify different UDPglucuronyltransferases have 
7 8 9 been unsuccessful ' ' . 
UDPglucuronyltransferase is associated with hepatic endo­
plasmic reticulum membranes. Enzyme solubilization has been 
tried with ultrasonication and treatment with digitonin, 
7 8 9 10 11 
various snake venoms, deoxycholate and lubrol ' ' ' ' . 
The 100,000 χ g supernatant fraction of microsomes treated 
with ultrasonication or deoxycholate contains enzymatically 
active membrane fragments. Preparations not containing these 
fragments are inactive . With these preparations as starting 
material, UDPglucuronyltransferase was purified to a limi­
ted extent7'8'9. 
Treatment of microsomes with phospholipase A inactivates 
UDPglucuronyltransferase and activity is restored upon addi-
io 13 
tion of phospholipid micelles ' indicating that lipid is 
probably required for UDPglucuronyltransferase activity. Pu­
rification of membrane proteins inevitably results in dis­
solution of their lipid environment. During purification of 
cytochrome P-450 ' cytochrome b
c
 and NADH cytochrome b,. 
17 
reductase gel filtration and ion exchange techniques in 
the presence of detergents disturb protein-lipid relation­
ships; the purified enzymes were in delipidated, non-parti-
culate fractions and enzyme activity was reduced ' ' ' 
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These enzymes function normally when bound to microsomal 
membranes or in the presence of phospholipid ' ' ' 
In the present study, UDPglucuronyltransferase activity was 
fully restored on addition of lipid fractions to a delipi-
dated, inactive preparation. An understanding of this pro-
blem is considered essential for ultimate purification and 
functional characterization of the enzyme protein. 
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MATERIAL AND METHODS 
Animals 
Adult male Wistar and homozygous UDPglucuronyltransferase 
deficient (GunnJ rats, weiçrhing 200- 250 g, were used, and 
were fed rat breeder chow and water ad libitum. 
Chemicals 
Bilirubin, uridine 5' diphosphoglucuronic acid (ammonium 
salt), and uridine 5' diphosphoglucose were obtained from 
Sigma, St. Louis, Mo; p-nitrophenol was from Calbiochem, 
San Diego, Calif; glycerol was from Fisher Scientific Com-
pany, Fair Lawn, N.J; deoxycholic acid, sodium salt was ob-
tained from Sigma, St. Louis, Mo.; and ethyl anthranilate 
was obtained from Eastman Kodak Company, Rochester, N.Y. 
For phosphorus quantitation, the Fiske and Subarrow reducer 
from Sigma, St. Louis, Mo., was used. Trizma Base, Sigma, 
St. Louis, Mo. was used for preparation of buffers. Glacial 
acetic acid, analytical grade, was from Mallinckrodt Chemi-
cal Works, St. Louis, Mo. All buffers were prepared with 
deionized distilled water. Bovine serum albumin was obtai-
ned from Sigma, St. Louis, Mo. Egg L-a-Lecithin, chromato-
graphically pure, was obtained from General Biochemicals, 
San Diego, Calif. Lysofree A grade, synthetic L-a-cephalin 
(β, γ dipalmitoyl) and purified bovine brain phosphatidyl 
serine, A grade, were obtained from Calbiochem, San Diego, 
Calif. 
Bio Gel P30 (100-200 mesh) was obtained from Bio Rad, Rich­
mond, Calif. For thinlayer chromatography, glass plates pre-
coated with Silica Gel G, layer thickness 0.25 mm, size 
20 χ 20 cm (Analtech Inc.) distributed by Fisher Scientific 
Company, Pittsburgh, Pa. were used. 
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Preparation of microsomes 
All procedures were performed in a cold room at 40C. Wistar 
rats and homozygous Gunn rats were killed by decapitation un­
der light ether anesthesia. The livers were removed immedia­
tely, perfused with 50 ml ice-cold saline and cut into small 
pieces. A 15% (w/v) homogenate was prepared with a Teflon-
glass homogenizer in 0.2 M Tris acetate buffer, pH 8.1, con­
taining 0.25 M sucrose and 0.2 mM disodium EDTA. The homoge­
nate was centrifugea at 650 χ g for 15 min. in swinging buc­
kets (IEC PR-J centrifuge, Damon IEC Division). The superna­
tant was centrifuged twice at 9000 χ g for 15 min (rotor, 
SS-34; Servali, superspeed, automatic refrigerated centrifu­
ge, RC-2, Sorvall, Newton, Conn.). The fatty layer on top of 
the 90 00 χ g supernatant was carefully removed by suction and 
a microsomal fraction was prepared from the remaining super­
natant by centrifugation at 100,000 χ g for 60 min (Beckmann 
L2-65 В ultracentrifuge) in pre-weighed tubes. After centri-
fugation, the supernatant was removed, the tubes were re-
weighed and the pellets were resuspended with a few strokes 
of the Teflon-glass homogenizer in 4 ml 0.02 M Tris acetate 
buffer, pH 8.1: glycerol (9:1 v/v) per gram of pellet. The 
suspensions were stored in a liquid nitrogen freezer (-180oC) 
The microsomal fraction from Wistar and Gunn rat liver were 
stored up to three weeks. Storage did not alter UDPglucuro-
nyltransferase activity with bilirubin or p-nitrophenol as 
substrates. 
Solubilization and delipidation 
Microsomal suspensions from Wistar rat liver were thawed at 
40C and 1 ml 0.02 M Tris acetate buffer, pH 8.1: glycerol 
(9:1, v/v) containing 15 mg deoxycholate was added per 4 ml 
suspension. After standing for 20 min at 4 С, this suspension 
was centrifuged at 100,000 χ g for 60 min. Centrifugation re-
suited in a clear supernatant, a loose cloudy fraction at the 
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Dottora of the tube and a small translucent pellet. Only the 
clear supernatant was processed further. Bovine serum albu­
min was added to the supernatant fraction (4 mg/ml]. Two 
samples of 4 ml each were applied to two identical columns 
(Pharmacia K26/70, 2.6 χ 70 cm, bed volume 370 ml) previous­
ly packed with Bio Gel P30 which was equilibrated with 0.02 
M Tris acetate, pH 8.1: glycerol (9:1, v/vj containing 
4.8 mM sodium deoxycholate, 0.1 M NaCl and 0.1 mM disodium 
EDTA (modification of the procedure by Rogers and Stritt­
ig 
matter ). The same buffer was used for elution. 
Enzyme Reaetivat-Con 
Immediately after elution from Bio Gel, samples with the 
highest protein concentration were combined with a mixed li­
pid preparation, commercial phospholipids or Gunn rat liver 
microsomes. The protein-lipid or the protein-microsome mix­
tures were dialyzed against 4 Liters of 0.0 2 M Tris acetate 
pH 7.25: glycerol (97.4: 2.6, v/v) containing 5 mM MgCl2. 
Dialysis was performed for 6 hours at 180C and for 16 hours 
at 40C. 
After dialysis, the fractions were diluted (1:1, v/v) with 
0.02 M Tris acetate, pH 8.1 containing 0.25 M sucrose and 
0.2 mM disodium EDTA. These solutions were centrifugea at 
100,000 χ g for 60 min. The resulting pellet was resuspended 
in Tris-sucrose-EDTA buffer with a few strokes of the Teflon-
glass homogenizer. 
The enzyme assay was immediately performed. 
Lipid preparations 
Lipids were extracted from microsomal preparations from Wis-
20 tar rat liver by the method of Folch et al . The organic 
solvent was evaporated from the lipid extract by a stream of 
nitrogen while keeping the solution at 370C. The lipids were 
dispersed in 0.02 M Tris acetate, pH 8.1: glycerol (9:1, v/v) 
by ultrasonication (Sonifier Cell Disruptor, Model W 14.0, 
Heat Systems and. Ultrasonics, Inc., Plainview, N.Y.). Phos­
pholipids from commercial preparations were dissolved in the 
same way. 
Enzyme assay 
The conjugation of bilirubin with glucuronic acid was deter-
21 
mined exactly as decribed previously . Incubation mixtures 
(volume: 1.2 ml5 contained 0.2 ml enzyme preparation and 8 3 
μΜ bilirubin, 3mM UDPglucuronate and 3.3 mM M Cl ?. For deter­
mination of bilirubin glucosidation, UDPglucuronate was repla­
ced by 3 mM UDPglucose. The mixtures were incubated at 37 С 
in a shaking water bath for 20 min. Diazo reaction and mea­
surement of the azopigments were performed as described by 
22 Fevery et al . Nature of the azopigments was confirmed by 
22 thin-layer chromatography 
The assay for p-nitrophenol glucuronidation was according to 
23 Henderson and Kersten . Incubation mixtures (volume: 0.6 ml) 
contained 0.1 ml enzyme preparation and 1.66 mM p-nitrophe­
nol, 3mM UDPglucuronate and 3.3 mM MgCl-. The mixtures were 
incubated for 20 min. at 370C. 
Other determinations 
24 Protein was determined according to Lowry et al . The phos-
25 phorus assay of Bartlett et al. was used. Multiplication of 
the phosphorus concentration by the conversion factor 25 gave 
the phospholipid concentration. 
Phospholipid analysis was performed by thin-layer chromato­
graphy with chloroform:methanol:water (65:25:4 v/v/v) as sol­
vent system. After development, the plates were sprayed with 
ninhydrin (0.25%, w/v) in 90% butanol, heated for 5 min. at 
90 C, sprayed again with 80% sulfuric acid, and heated for 10 
min at 120 С prior to examination. 
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RESULTS 
As shown in Table I, total activity (activity in pellet + su-
pernatant 1 with regard to glucuronidation of p-nitrophenol 
and bilirubin, increased considerably as a result of deoxy-
cholate treatment. Maximal activation occured at 10 mg deo-
xycholate per g microsomal pellet. No activation was found 
for glucosidation of bilirubin. For maximal solubilization, 
a somewhat higher amount of deoxycholate, 15 mg per gram mi-
crosomal pellet, was required. Higher deoxycholate concentra-
tions were inhibitory for glucuronidation of p-nitrophenol 
and bilirubin. Supernatant glucosidation was not signifi-
cantly different at 10, 15 and 20 mg deoxycholate per gram 
microsomal pellet. 
The data in Table I are ratios calculated on basis of acti-
vity per ml enzyme suspension. Calculation of ratios on ba-
sis of activity per mg microsomal protein, yielded similar 
results. Deoxycholate treatment did not result in selective 
solubilization of UDPglucuronyltransferase nor of the gluco-
syl transferase activity. These enzymes were simply solubi-
lized with the bulk of the microsomal proteins. Bovine serum 
albumin was added to the solubilized fraction (microsomal 
protein : albumin was approximately 2:1, w/w) and this solu-
tion was applied to a Bio Gel P30 column. Elution with a deo-
xycholate containing buffer resulted in separation of the 
microsomal proteins and phospholipids (Figure 1). The elution 
buffer contained 10% glycerol. At 20% glycerol, no separation 
was obtained. In the absence of glycerol or albumin, enzyme, 
activity was irreversibly destroyed. Chromatography on Bio 
Gel P30 resulted in extraction of 92% of the phospholipids. 
Thin layer chromatography of the Folch extract from the deli-
pidated preparation revealed only one clear circumscribed 
spot with the same Rf and color as glycerol. 
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The delipidated protein was completely inactive enzymatical-
ly (Table II).. Dialysis of delipidated protein together with 
mixed lipid extracted from Wistar rat microsomes, reactivated 
bilirubin glucuronidation. The reactivated preparation was 
concentrated by centrifugation and precipitated by centrifu-
gation at 100,000 χ g (Table II). 
Dialysis of the delipidated protein together with microsomes 
from UDPglucuronyltransferase deficient Gunn rat liver also 
resulted in an enzymatically active preparation (Table III). 
Reactivation only occured when delipidated protein and lipid 
preparations or Gunn rat liver microsomes were dialyzed to­
gether. Simple addition of the lipid preparation or Gunn rat 
microsomes to non-dialyzed delipidated protein or to the pro­
tein after dialysis did not result in reactivation. To rule 
out reactivation of Gunn rat microsomal protein, Gunn rat li­
ver microsomes were mixed with protein-free deoxycholate-
containing elution buffer (see Material and Methods). This 
suspension was dialyzed against 0.02 M Tris acetate, pH 7.25: 
glycerol (97.4: 2.6, v/v) containing 5 mM MgCl which did not 
result in reactivation. 
The optimal phospholipid / delipidated protein ratio was de­
termined by adding varying amounts of mixed lipid or Gunn 
rat microsomes to a constant amount of delipidated protein 
(Figure 2). The optimal ratio was approximately 1 when mixed 
lipids were used for reactivation, and approximately 2 when 
Gunn rat liver microsomes were used. 
Commercial preparations of lecithin, phosphatidyl serine and 
phosphatidyl ethanolamine were tested as reactivators of the 
delipidated preparation (Table IV). No reactivation was found 
with phosphatidyl ethanolamine. Lecithin was the most potent 
reactivating phospholipid preparation. Slight activity was 
found with phosphatidyl serine. However, thin layer chroma­
tography revealed that the phosphatidyl serine preparation 
contained a small amount of lecithin. The phosphatidyl etha­
nolamine preparation was contaminated with a small amount of 
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phosphatidyl serine. The lecithin preparation was chromato-
graphically pure. A lecithin/protein ratio of about 1 appea-
red to be optimal for both glucuronidation and glucosidation 
of bilirubin (Figure 3). 
Marked differences were found when enzyme activity in the re-
activated preparations was measured with different substrates. 
The preparation was completely inactive with p-nitrophenol as 
substrate for glucuronidation, (Table V). Relatively high ac-
tivity was found for glucosyl conjugation of bilirubin. The 
activity of the lecithin reactivated preparation amounted to 
181% as compared with bilirubin glucosidation activity in nor-
mal microsomes. Reactivation with respect to glucuronidation 
of bilirubin amounted to 90% when the optimal lecithin/pro-
tein ratio was used. 
The stability of the enzyme protein in the absence and pre-
sence of lecithin was tested. Delipidated protein was incu-
bated at 37 for 24 and 48 min , subsequently mixed with li-
pid and dialyzed. The activity of this preparation was com-
pared with a preparation incubated under the same circum-
stances after reactivation. The former preparation was con-
siderably more labile than the latter (Table VI) . Upon re-
activation, the reaction rate remained constant for at least 
20 min (Figure 4). 
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TABLE I ACTIVATION AND SOLUBIZATION OF OOVGLUCURONYLTRANSFERASE 
Substrates %Deoxycholate (w/w) t o t a l a c t i v i t y a c t i v i t y in supernatant 
0 
0.12 
1.51 
1.85 
1.26 
0 
0 
0.31 
0.20 
0.33 
0 
1.63 
3.73 
4.88 
2.81 
8ат Іев(2т^} from a miovoaomal визрепвгоп from Wistar rat liver ( 0.25 g тгаговотев 
/ ml) were mixed with 0.5 ml of a deoxyaholate solution of varying oonoentratione. 
Samples and deoxyaholate aontained 0.02 M Tris acetate buffer pH, 8.1: glycerol 
(9:1, v/v). After standing for 20 min at 4°, the samples were centrifugea at 100,000 
x g for 60 min. Enzyme activities were measured in the clear supernatant and in the 
pellet. The pellet was resuspended in a final volume of 2.5 ml. Total activity repre­
sents activity in pellet + supernatant. Activities were calculated per ml enzyme sus­
pension. The activity of the resuspended untreated pellet was called 1.00. 
1. bilirubin 
+ UDPglucuronate 
2. bilirubin 
+UDPglucose 
3. p-nitrophenol 
+UDPglucuronate 
0 
0.5 
1.0 
1.5 
2.0 
0 
0.5 
1.0 
1.5 
2.0 
0 
0.5 
1.0 
1.5 
2.0 
1.00 
3.18 
3.36 
2.76 
1.78 
1.00 
0.78 
1.03 
0.37 
0.33 
1.00 
6.55 
9.63 
7.50 
5.66 
TABLE II REACTIVATION OF BILIRUBIN GLUCURONIDATION WITH MIXED MICROSOMAL LIPID 
nmoles/mg protein mg protein/ml phospholipid/protein 
delipidated protein О 3.7Θ 0.06 
reactivated preparation 
-after dialysis 2.98 3.01 0.77 
-after centrifugation 
supernatant 0 1.81 0.33 
pellet 4.00 4.55 1.14 
Delipidated microsomal protein wae dialyzed together with mixed microsomal lipids 
as described in Material and Methods. After dialysis, an aliquot was removed for 
enzyme assay. The remainder was diluted 1:1 and centrifugea at 100,000 χ g for 60 
min. Enzyme activity was measured in supernatant and resuspended pellet. 
TABLE III REACTIVATION OF BILIRUBIN GLUCOBONIDAT ION BY MICROSOMAL MEMBRANES FROM 
THE GUNN RAT LIVER 
nmo 
delipidated protein 
Gunn rat microsomes 
reactivated preparation 
-after dialysis 
-after centrifugation 
supernatant 
pellet 
iles/mg protein 
0 
0 
1.04 (2.49) 
0 
0.85 
mg protein/ml 
3.78 
15.40 
8.80 
4.05 
20.00 
phospholipid/protein 
0.06 
0.59 
0.51 
0.18 
0.44 
Delipidated micvosomal protein from a Vistar rat was dialyzed with a microsomal pre-
paration from Gunn rat liver and processed as described in the legend of Table II. 
The value between brackets represents enzyme activity per mg Wistar rat protein. A 
correction was made for the presence of an estimated amount of Gunn rat liver micro-
somal protein. 
TABLE IV REACTIVATION OF BILIRUBIN GLUCURONIDATION BY DIFFERENT PHOSPHOLIPID 
PREPARATIONS 
nmoles/mg protein phospholipid/protein 
mixed lipid 
lecithin 
phosphatidyl serine 
phosphatidyl ethano-
lamine 
6.15 
6.24 
1.29 
0 
1.29 
2.97 
2.34 
2.95 
Delipidated microsomal protein wae dialyzed with different phospholipid prepara­
tions. Bilirubin g lu cur о nidation was assayed immediately after dialysis. 
00 
о 
TABLE V CONJUGATION OF BILIRUBIN AND P-NITROPHENOL WITH NORMAL MICROSOMES AND 
REACTIVATED PREPARATIONS 
microsomes 
delipidized protein 
reactivated with mixed 
lipid %reactivation 
reactivated with leci­
thin %reactivation 
bilirubin 
+UDPglucuronate 
12.00 
0 
4.71 
39 
10.79 
90 
bilirubin 
+UDPqlucose 
1.63 
0 
1.27 
78 
2.43 
181 
p-nitrophenol 
+UDPglucuronate 
474 
0 
0 
0 
phospholipid/ 
protein 
0.78 
0.06 
1.19 
1.02 
Gluauronidation of bilirubin and p-nitrophenol and glueoaidation of bilirubin were 
determined in normal microsomes and in reactivated preparations. 
TABLE VI STABILITI OF THE DELIPIDIZED PREPARATION BEFORE AND AFTER REACTIVATION 
Incubation at 37° -lecithin +lecithin ratio l i t h i n 
8. 
4. 
0. 
.22 
.69 
.36 
0 8.22 1 
24 7.15 0.66 
48 4.59 0.08 
The delipidated préparation wae incubated for 0,24 and 48 min at 37 , subsequently 
mixed with lecithin and dialyzed. Another sample of the delipidated preparation was 
mixed with lecithin, dialyzed and subsequently incubated at 37°, 
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Figure 1. Separation of microaomal •proteins and phospholipids fol­
lowing ahrornatography on Bio Gel P30. Vistar rat liver microsomes we-
treated with deoxyoholate (IS mg deoxy-oholate/gram miarosomal pel­
let] and chromatography of the 100,000 χ g supernatant was performed. 
The chromatography column contained Bio Gel P30. As equilibration and 
elution buffer, 0.2 M Tris acetate, pH 8.1: glycerol (9:1, ν/υ) con­
taining 4.8 sodium deoxycholate, 0.1 M NaCl and 0.1 mM disodium ^OTfi, 
was used. Before application to the column, the sample was mixed with 
bovine serum albumin (4 mg/ml). 
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Figure 4. Bilirubin glucuronidation as func­
tion of incubation time. Delipidated protein 
was mixed with lecithin in the optimal lecithin/ 
protein ratio. After dialysis and centrifugation 
(100,000 χ g, for 1 hour), bilirubin glucuroni­
dation was measured in the reauspended pellet. 
SS 
DISCUSSION 
UDPglucuronyltransferase is solubilized in an. active form by 
ft ? fi 
treating rat liver microsomes with deoxycholate ' . Chroma­
tography on Bio Gel P30 extracted 9 2% of phospholipids from 
this preparation. Similar chromatography of digitonin solu­
bilized preparations resulted in less complete protein-lipid 
separation. On removal of deoxycholate from the delipidated 
protein by dialysis, extensive precipitates were formed in 
the dialysis bags, indicating insolubility of the proteins. 
The reactivated UDPglucuronyltransferase preparation was al­
so insoluble and easily concentrated by centrifugation. 
Phospholipids are required for the function of many microso­
mal enzymes. Lecithin is required for reduction of cytochrome 
18 P-450 ; a lecithin-lysolecithin mixture reactivates delipi-
27 dated NADH-cytochrome reductase ; and phosphatidylethanola-
28 
mine is required for glucose 6-phosphatase activity . In 
the present study, three phospholipids were tested. Lecithin, 
but not phosphatidylserine or phosphatidylethanolamine, re­
activated UDPglucuronyltransferase activity in a delipidated 
preparation. Reactivation was obtained only after dialysing 
the delipidated protein together with phospholipid or Gunn 
rat liver microsomes. Simple addition of phospholipid or Gunn 
rat microsomes to delipidated protein did not result in re­
activation. This suggests that the enzyme protein must bind 
to phospholipid or microsomal membranes in order to regain 
UDPglucuronyltransferase activity. The lecithin-bound form 
was more stable at 37° than the free form. The function of 
lecithin may be to confer specific conformation to the en­
zyme protein which renders it enzymatically active and sta-
Ы е
2 9
. 
The substrate specificity of preparations reactivated with 
mixed phospholipids or lecithin was tested. These prepara­
tions catalyzed the formation of bilirubinglucuronide but 
86 
not p-nitrophenylglucuronide. Glucosidation of bilirubin was 
also catalyzed by the reactivated preparation. Delipidation 
irreversibly inactivates UDPglucuronyltransferase activity 
for p-nitrophenol glucuronidation. This suggests that sub-
strate specificity of UDPglucuronyltransferase is not a func-
tion of a phospholipid subunit of the enzyme but that forma-
tion of bilirubinglucuronide requires an enzyme protein which 
does not accept p-nitrophenol as substrate. 
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SUMMARY 
The conjugation of bilirubin and p-nitrophenol with glucu-
ronic acid was studied. The que&tion whether UDPglucuronyl-
transferase is one enzyme which catalyzes the glucuronida-
tion of various compounds, or a group of enzymes in which 
each enzyme specifically catalyzes certain reactions was 
the main issue of the study. 
First the glucuronidation of various substrates was studied, 
before and after treatment of test animals with phénobarbi-
tal. The glucuronidation activity was tested with microso-
mal preparations prepared from liver homogenates from Wis-
tar rats, homo- and heterozygous Gunn rats and cats. It was 
found that the bilirubin glucuronidation of Wistar rat and 
cat was increased after a twelve day treatment with phéno-
barbital. The glucuronidation activity determined with p-ni-
trophenol as substrate was already increased after 6 days 
phénobarbital. Another difference between the glucuronida-
tion of these two substrates was found with the homozygous 
Gunn rat. This animal is a mutant unable to form bilirubin 
glucuronides. Pre-treatment with phénobarbital did not af-
fect their deficient bilirubin glucuronidation capacity. 
The unimpaired capacity to form p-nitrophenylglucuronide of 
the homozygous Gunn rat however was largely increased after 
pretreatment with phénobarbital. These results suggest that 
different enzymes may play a role in the glucuronidation of 
the endogenous substrate bilirubin and the artifical sub-
strate p-nitrophenol. 
In the literature the assumption prevailed that the glucuro-
nidation of bilirubin is a simple one step reaction and the 
question how the conjugation of bilirubin with two glucuro-
nic acid molecules is effected has not been answered. The 
question however is of fundamental importance to understand 
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the biochemistry of the bilirubin glucuronidation and the 
interaction of drugs and other foreign compounds with this 
process. 
It was found that incubation of bilirubin and UDPglucuronate 
with, liver microsomes of the cat at pH 8, resulted in the 
formation of bilirubin mono- and diglucuronide. Relatively 
more diglucuronide was formed with microsomes treated with 
Tween 80 than with microsomes treated with Triton X-100 or 
untreated microsomes. About the same total amount of bili-
rubin glucuronide was formed with microsomes treated with 
Tween 80 and Triton X-100. Besides these detergents also al-
bumin influenced the relative amounts of mono- and diglucu-
ronide. With albumin in the incubation medium relatively 
more mono- and diglucuronide was formed compared with incu-
bations performed in the absence of albumin. These data show 
that the formation of biiirufcin dxglucuronide occurs in two 
steps whereby first the monoglucuronide is formed which is 
subsequently converted into diglucuronide. These data also 
show that both steps can proceed at pH 8. With bilirubin mo-
noglucuronide as substrate a bimodal pH curve was found for 
diglucuronide formation. Equal amounts of diglucuronide were 
formed at pH 8.0 and pH 6.5. 
Incubation of bilirubin and UDPglucuronate with microsomal 
preparations from Wistar rat liver by pH 8 resulted in the 
formation of bilirubin monoglucuronide. This in contrast to 
the results obtained with cat liver. For this reason Wistar 
rat liver could be used to prepare the substrate bilirubin 
monoglucuronide biosynthetically. 
Incubation of bilirubin monoglucuronide at pH 6.5 in the ab-
sence of an enzyme preparation also led to diglucuronide 
formation. This was a non-UDPglucuronate dependent reaction 
and could unequivocally be differentiated from the enzymical 
reaction. 
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The bilirubin glucuronidating form of UDPglucuronyltransfe-
rase proves to be an enzyme which is only active in the pre-
sence of phospholipids. A delipidated preparation prepared 
from microsomes from Wistar rat liver was inactive by the 
glucuronid^tion of bilirubin and p-nitrophenol. Rowever on-
ly the glucuronidation of bilirubin could be reactivated 
with phospholipids. The p-nitrophenol glucuronidation capa-
city of liver microsomes was apparently irreversible des-
troyed during delipic.ation. Also these latter results strong-
ly suggest that different glucuronyltransferases exist. 
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SAMENVATTING 
In deze studie werd de conjugatie van bilirubine en p-nitro-
phenol met glucuronzuur nader onderzocht. Met name de vraag 
of het UDPglucuronyltransferase één enzyme is, dat de glucu-
ronider ing van vele verschillende verbindingen kataliseert, 
of een groep van enzymen waarbij elk enzyme bij de katalyse 
van bepaalde specifieke reakties een rol speelt, stond bij de 
vraagstelling centraal. 
Allereerst werd de glucuronidering van verschillende substra-
ten, voor en na behandeling van de proefdieren met phénobar-
bital, bestudeerd. De glucuronideringsaktiviteit werd getest 
met microsomale preparaten, bereid uit leverhomogenaten van 
Wistar rat, homo- en heterozygote Gunn rat en kat. De bili-
rubine glucuronideringsaktiviteit van Wistar rat en kat was 
verhoogd na een 12 daagse behandeling met phénobarbital. De 
glucuronidering van p-nitrophenol was al na б dagen phénobar-
bital verhoogd. Een ander verschil tussen de glucuronidering 
van deze twee substraten werd gevonden met de homozygote 
Gunn rat. Dit proefdier kan geen bilirubine glucuronideren, 
ook niet na voorbehandeling met phénobarbital. De p-nitro-
phenol glucuronideringskapaciteit van de homozygote Gunn rat 
was sterk verhoogd na voorbehandeling met phénobarbital. De-
ze resultaten wijzer erop, dat mogelijk verschillende enzy-
men een rol spelen bij de glucuronidering van het endogene 
substraat bilirubine en de lichaamsvreemde stof p-nitrophe-
nol. 
Tot nu toe werd in de literatuur er veelal van uitgegaan dat 
de glucuronidering van bilirubine een simpele éénstapsreaktie 
is, en de vraag hoe de koppeling van bilirubine met twee mo-
leculen glucuronzuur tot stand komt was niet duidelijk be-
antwoord. Deze vraag is echter van fundamenteel belang om de 
biochemie van de bilirubine glucuronidering en de interactie 
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van lichaamsvreemde stoffen te begrijpen. 
Gevonden werd dat inkubatie van bilirubine met levermicro-
somen van de kat, in de aanwezigheid van UDPGA, bij pH 8 re-
sulteerde in de vorming van bilirubine homo- en diglucuroni-
de. Met Tween 80 behandelde microsomen werd relatief veel 
meer diglucuronide gevormd dan met Triton X-100 behandelde 
of onbehandelde microsomen. Ook albumine was van invloed op 
de mono-diglucuronide verhouding. Indien de reaktie werd uit-
gevoerd in de aanwezigheid van albumine bevatte het inkuba-
tie medium aan het eind van de reaktie veel meer mono- dan 
diglucuronide vergeleken met een reaktie die plaats vond in 
de afwezigheid van albumine. Deze gegevens duiden erop, dat 
de vorming van diglucuronide in twee stappen gebeurd, waar-
bij eerst het monoglucuronide wordt gevormd, dat in een twee-
de stap in diglucuronide wordt omgezet. Deze gegevens beteke-
nen tevens dat bij pH 8 beide reaktie stappen kunnen plaats 
vinden. Met bilirubine monoglucuronide als substraat werd 
een bimodale pH curve gevonden voor de diglucuronide vorming. 
Bij pH 6.5 en pH 8 werden gelijke hoeveelheden diglucuronide 
gevormd. Veel minder diglucuronide werd gevormd bij tussen 
deze twee waarden gelegen pH's. 
Inkubatie van bilirubine met levermicrosomen van de Wistar 
rat bij de pH 8 leidde tot de vorming van voornamelijk bili-
rubine monoglucuronide. Bij de bereiding van het bilirubine 
monoglucuronide werd hiervan gebruik gemaakt. 
Inkubatie van bilirubine monoglucuronide bij pH 6.5 in de 
afwezigheid van een enzyme preparaat leidde ook tot diglucu-
ronide vorming. Deze niet-enzymatische reaktie kon op ondub-
belzinnige wijze van een enzymatische reaktie worden onder-
scheiden. 
De bilirubine glucuroniderende vorm van het UDPglucuronyl-
transferase blijkt een enzyme te zijn dat alleen werkzaam is 
in de aanwezigheid van phospholipiden. Een gedelipideerd pre-
paraat bereid van levermicrosomen van de Wistar rat was on-
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werkzaam bij de glucuronidering van. p-nitrophenol en bili-
rubine. 
Alleen de bilirubine glucuronidering kon echter met behulp 
van phospholipiden worden gereaktiveerd. Deze laatste bevin-
ding is een sterk argument dat bij de glucuronidering van de-
ze twee substraten verschillende enzymen betrokken zijn. 
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